<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>META-SPRINT: 40 d√≠as para obtener evidencia confiable</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,400;0,600;0,700;1,400;1,600&amp;family=Source+Sans+Pro:wght@300;400;600;700&amp;display=swap" rel="stylesheet"/>
<style>
    :root {
      --navy: #1E2761;
      --deep-navy: #141B3D;
      --gold: #D4AF37;
      --cream: #FAF8F5;
      --light-cream: #FFFFFF;
      --text: #2D3748;
      --light-text: #718096;
      --red: #C53030;
      --green: #22c55e;
      --teal: #0f766e;
      --purple: #7c3aed;
      --orange: #f59e0b;
      --transition: 0.5s cubic-bezier(0.4, 0, 0.2, 1);
    }

    * { margin: 0; padding: 0; box-sizing: border-box; }
    html, body {
      height: 100%;
      font-family: 'Source Sans Pro', sans-serif;
      background: var(--deep-navy);
      color: var(--cream);
    }

    .course-container { display: flex; height: 100vh; overflow: hidden; }

    /* ====== SIDEBAR ====== */
    .sidebar {
      width: 300px;
      background: linear-gradient(180deg, var(--deep-navy) 0%, #0a0f1a 100%);
      border-right: 1px solid rgba(212,175,55,0.2);
      display: flex;
      flex-direction: column;
      flex-shrink: 0;
    }

    .sidebar-header {
      padding: 1.25rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      text-align: center;
    }
    .sidebar-header h1 {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.3rem;
      font-weight: 700;
      color: var(--gold);
    }
    .sidebar-header p {
      font-size: 0.75rem;
      color: rgba(255,255,255,0.6);
    }

    /* Gamification Stats Panel */
    .stats-panel {
      padding: 1rem;
      background: rgba(212,175,55,0.1);
      border-bottom: 1px solid rgba(212,175,55,0.2);
    }
    .level-display {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 0.75rem;
    }
    .level-badge {
      width: 48px;
      height: 48px;
      background: linear-gradient(135deg, var(--gold), #f0c040);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.5rem;
      box-shadow: 0 2px 8px rgba(212,175,55,0.4);
    }
    .level-info { flex: 1; }
    .level-title { font-weight: 700; font-size: 0.9rem; color: var(--gold); }
    .level-subtitle { font-size: 0.7rem; color: rgba(255,255,255,0.6); }
    .xp-bar {
      height: 8px;
      background: rgba(255,255,255,0.1);
      border-radius: 4px;
      overflow: hidden;
      margin-top: 0.5rem;
    }
    .xp-fill {
      height: 100%;
      background: linear-gradient(90deg, var(--gold), var(--orange));
      border-radius: 4px;
      transition: width 0.5s ease;
    }
    .xp-text {
      font-size: 0.65rem;
      color: rgba(255,255,255,0.5);
      text-align: right;
      margin-top: 0.25rem;
    }
    .quick-stats {
      display: grid;
      grid-template-columns: repeat(3, 1fr);
      gap: 0.5rem;
      margin-top: 0.75rem;
    }
    .quick-stat {
      background: rgba(0,0,0,0.2);
      padding: 0.5rem;
      border-radius: 6px;
      text-align: center;
    }
    .quick-stat-value {
      font-size: 1.1rem;
      font-weight: 700;
      color: var(--gold);
    }
    .quick-stat-label {
      font-size: 0.6rem;
      color: rgba(255,255,255,0.5);
    }

    .module-list { flex: 1; overflow-y: auto; padding: 0.5rem 0; }
    .module-item {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      padding: 0.6rem 1rem;
      cursor: pointer;
      transition: all 0.2s;
      border-left: 3px solid transparent;
    }
    .module-item:hover { background: rgba(212,175,55,0.1); }
    .module-item.active { background: rgba(212,175,55,0.15); border-left-color: var(--gold); }
    .module-item.completed .module-number { background: var(--green); color: white; }
    .module-item.locked { opacity: 0.5; cursor: not-allowed; }
    .module-number {
      width: 26px;
      height: 26px;
      border-radius: 50%;
      background: rgba(255,255,255,0.1);
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.7rem;
      font-weight: 700;
      flex-shrink: 0;
    }
    .module-item.active .module-number { background: var(--gold); color: var(--navy); }
    .module-info { flex: 1; min-width: 0; }
    .module-title { font-size: 0.8rem; font-weight: 600; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; }
    .module-subtitle { font-size: 0.65rem; color: rgba(255,255,255,0.5); }
    .module-xp { font-size: 0.6rem; color: var(--gold); }

    /* Badges Panel */
    .badges-panel {
      padding: 1rem;
      border-top: 1px solid rgba(212,175,55,0.2);
    }
    .badges-title { font-size: 0.75rem; font-weight: 600; color: var(--gold); margin-bottom: 0.5rem; }
    .badges-grid { display: flex; flex-wrap: wrap; gap: 0.35rem; }
    .badge-item {
      width: 32px;
      height: 32px;
      min-width: 44px;
      min-height: 44px;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.1);
      border-radius: 6px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.9rem;
      font-family: inherit;
      color: inherit;
      padding: 0;
      opacity: 0.3;
      transition: all 0.3s;
      cursor: help;
      position: relative;
    }
    .badge-item.earned { opacity: 1; background: rgba(212,175,55,0.2); border-color: var(--gold); }
    .badge-item:hover::after {
      content: attr(data-tooltip);
      position: absolute;
      bottom: 100%;
      left: 50%;
      transform: translateX(-50%);
      background: var(--navy);
      color: white;
      padding: 0.25rem 0.5rem;
      border-radius: 4px;
      font-size: 0.6rem;
      white-space: nowrap;
      z-index: 100;
    }

    /* ====== MAIN CONTENT ====== */
    .main-content { flex: 1; display: flex; flex-direction: column; overflow: hidden; }
    .content-header {
      padding: 0.75rem 1.5rem;
      background: rgba(0,0,0,0.3);
      border-bottom: 1px solid rgba(212,175,55,0.2);
      display: flex;
      align-items: center;
      justify-content: space-between;
    }
    .breadcrumb { font-size: 0.85rem; color: rgba(255,255,255,0.6); }
    .breadcrumb span { color: var(--gold); }
    .header-actions { display: flex; gap: 0.5rem; align-items: center; }
    .streak-display {
      display: flex;
      align-items: center;
      gap: 0.35rem;
      background: rgba(239,68,68,0.2);
      border: 1px solid rgba(239,68,68,0.4);
      padding: 0.35rem 0.75rem;
      border-radius: 20px;
      font-size: 0.8rem;
    }
    .streak-display.active { background: rgba(249,115,22,0.2); border-color: var(--orange); }
    .streak-flame { font-size: 1rem; }
    .streak-count { font-weight: 700; color: var(--orange); }

    .btn {
      padding: 0.5rem 1rem;
      border: 1px solid rgba(212,175,55,0.3);
      border-radius: 6px;
      background: rgba(255,255,255,0.05);
      color: var(--cream);
      font-size: 0.8rem;
      cursor: pointer;
      transition: all 0.2s;
    }
    .btn:hover { background: rgba(212,175,55,0.2); border-color: var(--gold); }
    .btn.primary { background: var(--gold); color: var(--navy); border-color: var(--gold); font-weight: 600; }

    .content-body { flex: 1; overflow: hidden; display: flex; }

    /* ====== SLIDES ====== */
    .slides-container { flex: 1; position: relative; overflow: hidden; touch-action: pan-y pinch-zoom; }
    .module-slides { display: none; width: 100%; height: 100%; }
    .module-slides.active { display: block; }

    .slide {
      position: absolute;
      top: 0; left: 0;
      width: 100%; height: 100%;
      display: flex;
      flex-direction: column;
      justify-content: flex-start;
      align-items: center;
      padding: 2rem 2rem 4rem;
      opacity: 0;
      visibility: hidden;
      transition: opacity var(--transition), visibility var(--transition);
      overflow-y: auto;
    }
    .slide.active { opacity: 1; visibility: visible; }
    .slide.dark { background: var(--deep-navy); }
    .slide.light { background: var(--cream); color: var(--text); }
    .slide.black { background: #000; }
    .slide.red-bg { background: linear-gradient(135deg, #7f1d1d, #450a0a); }
    .slide.green-bg { background: linear-gradient(135deg, #14532d, #052e16); }
    .slide.purple-bg { background: linear-gradient(135deg, #4c1d95, #2e1065); }

    .serif { font-family: 'Cormorant Garamond', Georgia, serif; }
    .title {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: clamp(1.8rem, 4vw, 3rem);
      font-weight: 700;
      margin-bottom: 1rem;
      line-height: 1.2;
      text-align: center;
    }
    .title.gold { color: var(--gold); }
    .title.navy { color: var(--navy); }
    .subtitle {
      font-size: clamp(0.9rem, 2vw, 1.3rem);
      color: rgba(255,255,255,0.7);
      margin-bottom: 1.5rem;
      text-align: center;
    }
    .slide.light .subtitle { color: var(--light-text); }

    .big-number {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: clamp(4rem, 12vw, 8rem);
      font-weight: 700;
      line-height: 1;
    }
    .big-number.gold { color: var(--gold); }
    .big-number.red { color: var(--red); }

    .refrain {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: clamp(1.3rem, 3vw, 2rem);
      font-style: italic;
      color: var(--gold);
      text-align: center;
      max-width: 700px;
    }

    .content { display: flex; flex-direction: column; align-items: center; width: 100%; max-width: 850px; }

    /* Cards */
    .card {
      background: var(--light-cream);
      border: 1px solid var(--gold);
      padding: 1.25rem 1.5rem;
      margin: 0.5rem 0;
      max-width: 750px;
      width: 100%;
      border-radius: 8px;
    }
    .card.navy-bg { background: var(--navy); color: var(--cream); }
    .card.red-border { border: 2px solid var(--red); }
    .card.green-border { border: 2px solid var(--green); }
    .card-label {
      font-size: 0.7rem;
      font-weight: 700;
      color: var(--gold);
      letter-spacing: 0.05em;
      margin-bottom: 0.4rem;
      text-transform: uppercase;
    }
    .card-text { font-size: 0.95rem; line-height: 1.6; }
    .card.navy-bg .card-text { color: var(--cream); }

    /* Story box */
    .story-box {
      background: linear-gradient(135deg, rgba(197,48,48,0.15), rgba(30,39,97,0.2));
      border-left: 4px solid var(--red);
      padding: 1.25rem;
      margin: 0.75rem 0;
      max-width: 750px;
      width: 100%;
      border-radius: 0 8px 8px 0;
    }
    .story-box.success { background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(30,39,97,0.2)); border-left-color: var(--green); }
    .story-box.warning { background: linear-gradient(135deg, rgba(245,158,11,0.15), rgba(30,39,97,0.2)); border-left-color: var(--orange); }
    .story-label {
      font-size: 0.7rem;
      font-weight: 700;
      letter-spacing: 0.1em;
      color: var(--red);
      margin-bottom: 0.4rem;
      text-transform: uppercase;
    }
    .story-box.success .story-label { color: var(--green); }
    .story-box.warning .story-label { color: var(--orange); }
    .story-text { font-size: 0.95rem; line-height: 1.6; }

    /* Epic Story Box */
    .story-box.epic {
      background: linear-gradient(135deg, rgba(20,27,61,0.95), rgba(0,0,0,0.9));
      border-left: 4px solid var(--gold);
      border-top: 1px solid rgba(212,175,55,0.3);
      border-right: 1px solid rgba(212,175,55,0.2);
      border-bottom: 1px solid rgba(212,175,55,0.2);
      padding: 1.5rem;
      position: relative;
    }
    .story-box.epic::before {
      content: '';
      position: absolute;
      top: 0;
      left: 0;
      right: 0;
      height: 2px;
      background: linear-gradient(90deg, var(--gold), transparent);
    }
    .story-box.epic .story-label { color: var(--gold); font-size: 0.65rem; letter-spacing: 0.15em; }
    .story-box.epic .story-text { font-family: 'Cormorant Garamond', Georgia, serif; font-size: 1.05rem; line-height: 1.7; }
    .story-box.epic .story-moral {
      margin-top: 1rem;
      padding-top: 1rem;
      border-top: 1px solid rgba(212,175,55,0.2);
      font-style: italic;
      color: var(--gold);
      font-size: 0.95rem;
    }

    /* Stats */
    .stats-grid {
      display: flex;
      gap: 0.75rem;
      margin: 1rem 0;
      flex-wrap: wrap;
      justify-content: center;
    }
    .stat-box {
      background: var(--navy);
      color: var(--cream);
      padding: 1rem 1.25rem;
      text-align: center;
      min-width: 120px;
      border-radius: 8px;
    }
    .stat-box.light { background: var(--light-cream); color: var(--navy); border: 1px solid var(--gold); }
    .stat-value {
      font-family: 'Cormorant Garamond', serif;
      font-size: clamp(1.3rem, 2.5vw, 2rem);
      font-weight: 700;
    }
    .stat-value.gold { color: var(--gold); }
    .stat-value.red { color: var(--red); }
    .stat-label { font-size: 0.75rem; opacity: 0.8; margin-top: 0.2rem; }

    /* Timeline */
    .timeline { display: flex; flex-direction: column; gap: 0.4rem; width: 100%; max-width: 650px; }
    .timeline-item {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      padding: 0.6rem 0.75rem;
      background: rgba(255,255,255,0.05);
      border-radius: 6px;
      border-left: 4px solid var(--gold);
    }
    .timeline-item.phase-a { border-left-color: var(--purple); }
    .timeline-item.phase-b { border-left-color: #3b82f6; }
    .timeline-item.phase-c { border-left-color: var(--orange); }
    .timeline-item.phase-d { border-left-color: var(--green); }
    .timeline-item.phase-e { border-left-color: var(--red); }
    .timeline-days { font-weight: 700; font-size: 0.8rem; min-width: 70px; color: var(--gold); }
    .timeline-content { flex: 1; }
    .timeline-title { font-weight: 600; font-size: 0.9rem; }
    .timeline-desc { font-size: 0.75rem; opacity: 0.7; }

    /* Checklist */
    .checklist { display: flex; flex-direction: column; gap: 0.4rem; width: 100%; max-width: 650px; }
    .checklist-item {
      display: flex;
      align-items: flex-start;
      gap: 0.6rem;
      padding: 0.6rem 0.75rem;
      background: rgba(255,255,255,0.05);
      border-radius: 6px;
      border: 1px solid rgba(255,255,255,0.1);
    }
    .check-icon {
      width: 22px;
      height: 22px;
      background: var(--gold);
      color: var(--navy);
      border-radius: 4px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.75rem;
      flex-shrink: 0;
    }
    .checklist-text { font-size: 0.9rem; line-height: 1.4; }

    /* Lessons */
    .lesson-item { display: flex; align-items: flex-start; gap: 0.75rem; margin: 0.5rem 0; max-width: 700px; }
    .lesson-number {
      background: var(--gold);
      color: var(--navy);
      width: 28px;
      height: 28px;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.85rem;
      flex-shrink: 0;
    }
    .lesson-content h4 { font-size: 1rem; font-weight: 700; margin-bottom: 0.2rem; }
    .lesson-content p { font-size: 0.85rem; opacity: 0.8; }

    /* ====== DECISION TREE ====== */
    .decision-tree {
      width: 100%;
      max-width: 700px;
      background: linear-gradient(135deg, rgba(124,58,237,0.15), rgba(30,39,97,0.25));
      border: 2px solid var(--purple);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 0.75rem 0;
    }
    .decision-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 1rem;
    }
    .decision-icon {
      width: 40px;
      height: 40px;
      background: var(--purple);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.25rem;
    }
    .decision-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.2rem;
      font-weight: 700;
    }
    .decision-xp {
      margin-left: auto;
      background: rgba(212,175,55,0.2);
      padding: 0.25rem 0.75rem;
      border-radius: 12px;
      font-size: 0.75rem;
      color: var(--gold);
      font-weight: 600;
    }
    .decision-scenario {
      background: rgba(0,0,0,0.2);
      padding: 1rem;
      border-radius: 8px;
      margin-bottom: 1rem;
      font-size: 0.95rem;
      line-height: 1.6;
    }
    .decision-question {
      font-weight: 600;
      color: var(--gold);
      margin-bottom: 0.75rem;
      font-size: 1rem;
    }
    .decision-options { display: flex; flex-direction: column; gap: 0.5rem; }
    .decision-option {
      display: flex;
      align-items: flex-start;
      gap: 0.75rem;
      padding: 0.75rem 1rem;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.15);
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.2s;
    }
    .decision-option:hover { background: rgba(124,58,237,0.2); border-color: var(--purple); }
    .decision-option.selected { background: rgba(124,58,237,0.3); border-color: var(--purple); }
    .decision-option.correct { background: rgba(34,197,94,0.2); border-color: var(--green); }
    .decision-option.incorrect { background: rgba(239,68,68,0.15); border-color: var(--red); }
    .decision-option.disabled { pointer-events: none; opacity: 0.7; }
    .option-letter {
      width: 24px;
      height: 24px;
      background: rgba(255,255,255,0.1);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.8rem;
      flex-shrink: 0;
    }
    .decision-option.correct .option-letter { background: var(--green); color: white; }
    .decision-option.incorrect .option-letter { background: var(--red); color: white; }
    .option-text { font-size: 0.9rem; }
    .decision-feedback {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
    }
    .decision-feedback.show { display: block; }
    .decision-feedback.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .decision-feedback.incorrect { background: rgba(239,68,68,0.15); border: 1px solid var(--red); }
    .feedback-title { font-weight: 700; margin-bottom: 0.5rem; display: flex; align-items: center; gap: 0.5rem; }
    .feedback-text { font-size: 0.9rem; line-height: 1.5; }

    /* ====== PREDICTION ====== */
    .prediction-panel {
      width: 100%;
      max-width: 700px;
      background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(30,39,97,0.25));
      border: 2px solid var(--gold);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 0.75rem 0;
      text-align: center;
    }
    .prediction-icon { font-size: 2.5rem; margin-bottom: 0.5rem; }
    .prediction-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.3rem;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .prediction-subtitle { font-size: 0.9rem; opacity: 0.8; margin-bottom: 1rem; }
    .prediction-buttons {
      display: flex;
      flex-direction: column;
      gap: 0.5rem;
    }
    .predict-btn {
      display: flex;
      align-items: center;
      justify-content: center;
      gap: 0.5rem;
      padding: 0.75rem 1rem;
      border: 2px solid;
      border-radius: 8px;
      font-size: 0.9rem;
      font-weight: 600;
      cursor: pointer;
      transition: all 0.2s;
      background: rgba(0,0,0,0.2);
    }
    .predict-btn.benefit { border-color: var(--green); color: var(--green); }
    .predict-btn.benefit:hover { background: rgba(34,197,94,0.2); }
    .predict-btn.neutral { border-color: var(--light-text); color: var(--light-text); }
    .predict-btn.neutral:hover { background: rgba(148,163,184,0.2); }
    .predict-btn.harm { border-color: var(--red); color: var(--red); }
    .predict-btn.harm:hover { background: rgba(239,68,68,0.2); }
    .predict-btn.selected { transform: scale(1.02); box-shadow: 0 0 15px rgba(255,255,255,0.1); }
    .prediction-result {
      margin-top: 1rem;
      padding: 0.75rem;
      border-radius: 8px;
      display: none;
    }
    .prediction-result.show { display: block; }
    .prediction-result.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .prediction-result.incorrect { background: rgba(239,68,68,0.15); border: 1px solid var(--red); }

    /* ====== QUIZ ====== */
    .quiz-container { width: 100%; max-width: 650px; }
    .quiz-question {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.2rem;
      margin-bottom: 1.25rem;
      text-align: center;
    }
    .quiz-options { display: flex; flex-direction: column; gap: 0.5rem; }
    .quiz-option {
      padding: 0.75rem 1rem;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.2);
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.2s;
      text-align: left;
      font-size: 0.9rem;
    }
    .quiz-option:hover { background: rgba(212,175,55,0.15); border-color: var(--gold); }
    .quiz-option.correct { background: rgba(34,197,94,0.2); border-color: var(--green); }
    .quiz-option.incorrect { background: rgba(239,68,68,0.15); border-color: var(--red); }
    .quiz-option.disabled { pointer-events: none; }
    .quiz-feedback {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
      font-size: 0.9rem;
    }
    .quiz-feedback.show { display: block; }
    .quiz-feedback.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .quiz-feedback.incorrect { background: rgba(239,68,68,0.15); border: 1px solid var(--red); }

    /* Crisis box */
    .crisis-box {
      background: linear-gradient(135deg, rgba(124,58,237,0.2), rgba(30,39,97,0.3));
      border: 2px solid var(--purple);
      border-radius: 12px;
      padding: 1.25rem;
      margin: 0.75rem 0;
      max-width: 750px;
      width: 100%;
    }
    .crisis-header { display: flex; align-items: center; gap: 0.75rem; margin-bottom: 0.75rem; }
    .crisis-number {
      width: 36px;
      height: 36px;
      background: var(--purple);
      color: white;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 1.1rem;
    }
    .crisis-title { font-family: 'Cormorant Garamond', serif; font-size: 1.15rem; font-weight: 700; }
    .crisis-day { font-size: 0.75rem; color: var(--purple); }

    /* Animation */
    .slide.active .animate { animation: fadeUp 0.5s ease-out forwards; }
    .slide.active .animate.delay-1 { animation-delay: 0.1s; }
    .slide.active .animate.delay-2 { animation-delay: 0.2s; }
    .slide.active .animate.delay-3 { animation-delay: 0.3s; }
    @keyframes fadeUp {
      from { opacity: 0; transform: translateY(15px); }
      to { opacity: 1; transform: translateY(0); }
    }
    .animate { opacity: 0; }

    /* XP Popup */
    .xp-popup {
      position: fixed;
      top: 50%;
      left: 50%;
      transform: translate(-50%, -50%) scale(0);
      background: linear-gradient(135deg, var(--gold), #f0c040);
      color: var(--navy);
      padding: 1.5rem 2.5rem;
      border-radius: 12px;
      font-family: 'Cormorant Garamond', serif;
      font-size: 2rem;
      font-weight: 700;
      z-index: 1000;
      box-shadow: 0 10px 40px rgba(0,0,0,0.5);
      transition: transform 0.3s ease;
    }
    .xp-popup.show { transform: translate(-50%, -50%) scale(1); }
    .xp-popup .xp-amount { font-size: 3rem; display: block; }

    /* Badge Earned Modal */
    .badge-modal {
      position: fixed;
      top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.85);
      display: none;
      justify-content: center;
      align-items: center;
      z-index: 1001;
    }
    .badge-modal.show { display: flex; }
    .badge-modal-content {
      background: linear-gradient(135deg, var(--deep-navy), #0a0f1a);
      border: 2px solid var(--gold);
      border-radius: 16px;
      padding: 2rem;
      text-align: center;
      max-width: 350px;
    }
    .badge-modal-icon { font-size: 4rem; margin-bottom: 1rem; }
    .badge-modal-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.5rem;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .badge-modal-desc { font-size: 0.9rem; opacity: 0.8; margin-bottom: 1rem; }
    .badge-modal-close {
      padding: 0.5rem 1.5rem;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 6px;
      font-weight: 600;
      cursor: pointer;
    }

    /* Confetti - respects reduced motion */
    .confetti-container {
      position: fixed;
      top: 0; left: 0;
      width: 100%; height: 100%;
      pointer-events: none;
      z-index: 999;
      overflow: hidden;
    }
    .confetti {
      position: absolute;
      width: 10px; height: 10px;
      opacity: 0;
      animation: confetti-fall 3s ease-out forwards;
    }
    @keyframes confetti-fall {
      0% { transform: translateY(-100px) rotate(0deg); opacity: 1; }
      100% { transform: translateY(100vh) rotate(720deg); opacity: 0; }
    }
    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
      }
      .confetti { display: none; }
    }

    /* Combo Counter */
    .combo-display {
      position: fixed;
      top: 80px;
      right: 20px;
      background: linear-gradient(135deg, var(--orange), #ef4444);
      color: white;
      padding: 0.5rem 1rem;
      border-radius: 20px;
      font-weight: 700;
      font-size: 0.9rem;
      z-index: 500;
      transform: scale(0);
      transition: transform 0.3s ease;
      box-shadow: 0 4px 15px rgba(239,68,68,0.4);
    }
    .combo-display.show { transform: scale(1); }
    .combo-display.big { transform: scale(1.2); }

    /* Key Takeaway Card */
    .takeaway-card {
      background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(30,39,97,0.2));
      border: 1px solid var(--green);
      border-radius: 8px;
      padding: 1rem 1.25rem;
      margin: 0.75rem 0;
      max-width: 700px;
      width: 100%;
    }
    .takeaway-card .takeaway-icon {
      display: inline-block;
      background: var(--green);
      color: white;
      width: 24px;
      height: 24px;
      border-radius: 50%;
      text-align: center;
      line-height: 24px;
      font-size: 0.8rem;
      margin-right: 0.5rem;
    }
    .takeaway-card .takeaway-label {
      font-size: 0.7rem;
      font-weight: 700;
      color: var(--green);
      text-transform: uppercase;
      letter-spacing: 0.05em;
      margin-bottom: 0.35rem;
    }
    .takeaway-card .takeaway-text {
      font-size: 0.9rem;
      line-height: 1.5;
      font-style: italic;
    }

    /* Module Time Estimate */
    .module-time {
      font-size: 0.55rem;
      color: rgba(255,255,255,0.4);
      display: flex;
      align-items: center;
      gap: 0.25rem;
      margin-top: 0.15rem;
    }

    /* Enhanced Focus States for Keyboard Navigation */
    .decision-option:focus-visible,
    .quiz-option:focus-visible,
    .predict-btn:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
    }
    .nav-btn:focus-visible,
    .btn:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
    }

    /* Progress within module */
    .slide-progress-bar {
      position: absolute;
      top: 0;
      left: 0;
      height: 3px;
      background: linear-gradient(90deg, var(--gold), var(--orange));
      transition: width 0.3s ease;
      z-index: 50;
    }

    /* Citation Link Style */
    .citation-link {
      font-size: 0.7rem;
      color: var(--gold);
      opacity: 0.7;
      text-decoration: none;
      display: inline-flex;
      align-items: center;
      gap: 0.25rem;
      margin-top: 0.5rem;
    }
    .citation-link:hover { opacity: 1; text-decoration: underline; }

    /* Mobile Sidebar Toggle */
    @media (max-width: 768px) {
      .sidebar {
        position: fixed;
        left: -300px;
        top: 0;
        bottom: 0;
        z-index: 1000;
        transition: left 0.3s ease;
      }
      .sidebar.open { left: 0; }
      .sidebar-toggle {
        display: flex;
        position: fixed;
        top: 10px;
        left: 10px;
        z-index: 1001;
        width: 40px;
        height: 40px;
        background: var(--gold);
        color: var(--navy);
        border: none;
        border-radius: 8px;
        align-items: center;
        justify-content: center;
        font-size: 1.2rem;
        cursor: pointer;
      }
      .sidebar-overlay {
        display: none;
        position: fixed;
        top: 0; left: 0; right: 0; bottom: 0;
        background: rgba(0,0,0,0.5);
        z-index: 999;
      }
      .sidebar-overlay.show { display: block; }
    }
    @media (min-width: 769px) {
      .sidebar-toggle { display: none; }
      .sidebar-overlay { display: none !important; }
    }

    /* Nav */
    .slide-nav {
      position: absolute;
      bottom: 0; left: 0; right: 0;
      display: flex;
      justify-content: space-between;
      align-items: flex-end;
      padding: 0.75rem 1rem 1.25rem;
      z-index: 100;
      pointer-events: none;
    }
    .nav-btn {
      background: rgba(0,0,0,0.5);
      border: 1px solid rgba(255,255,255,0.2);
      color: white;
      font-size: 1.1rem;
      cursor: pointer;
      opacity: 0.6;
      transition: all 0.2s;
      padding: 0.4rem 0.6rem;
      border-radius: 6px;
      pointer-events: auto;
    }
    .nav-btn:hover { opacity: 1; background: rgba(0,0,0,0.7); border-color: var(--gold); }
    .nav-btn:disabled { opacity: 0.2; cursor: not-allowed; }
    .nav-center { display: flex; flex-direction: column; align-items: center; gap: 0.2rem; pointer-events: auto; }
    .slide-counter { font-size: 0.7rem; opacity: 0.5; }
    .progress-dots { display: flex; gap: 3px; flex-wrap: wrap; max-width: 220px; }
    .progress-dot {
      width: 44px;
      height: 44px;
      display: flex;
      align-items: center;
      justify-content: center;
      cursor: pointer;
      background: none;
      border: none;
      padding: 0;
    }
    .progress-dot::after {
      content: '';
      width: 12px;
      height: 12px;
      border-radius: 50%;
      background: var(--text-muted, rgba(255,255,255,0.25));
      transition: all 0.2s ease;
    }
    .progress-dot.active::after,
    .progress-dot.completed::after {
      background: var(--gold);
      width: 14px;
      height: 14px;
    }

    /* Course Progress Bar */
    .course-progress {
      padding: 0.75rem 1rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      background: rgba(0,0,0,0.2);
    }
    .course-progress-label {
      display: flex;
      justify-content: space-between;
      font-size: 0.7rem;
      color: rgba(255,255,255,0.6);
      margin-bottom: 0.35rem;
    }
    .course-progress-bar {
      height: 6px;
      background: rgba(255,255,255,0.1);
      border-radius: 3px;
      overflow: hidden;
    }
    .course-progress-fill {
      height: 100%;
      background: linear-gradient(90deg, var(--green), #22d3ee);
      border-radius: 3px;
      transition: width 0.5s ease;
    }

    /* Learning Objectives */
    .objectives-box {
      background: linear-gradient(135deg, rgba(59,130,246,0.15), rgba(30,39,97,0.25));
      border: 2px solid #3b82f6;
      border-radius: 12px;
      padding: 1.25rem;
      margin: 0.75rem 0;
      max-width: 700px;
      width: 100%;
    }
    .objectives-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 0.75rem;
    }
    .objectives-icon {
      width: 36px;
      height: 36px;
      background: #3b82f6;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.1rem;
    }
    .objectives-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.1rem;
      font-weight: 700;
      color: #60a5fa;
    }
    .objectives-list {
      list-style: none;
      padding: 0;
    }
    .objectives-list li {
      display: flex;
      align-items: flex-start;
      gap: 0.5rem;
      padding: 0.4rem 0;
      font-size: 0.9rem;
    }
    .objectives-list li::before {
      content: '‚óã';
      color: #3b82f6;
      font-weight: bold;
    }
    .objectives-list li.completed::before {
      content: '‚óè';
      color: var(--green);
    }

    /* Module Summary */
    .summary-box {
      background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(30,39,97,0.25));
      border: 2px solid var(--green);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 0.75rem 0;
      max-width: 700px;
      width: 100%;
      text-align: center;
    }
    .summary-icon { font-size: 2.5rem; margin-bottom: 0.5rem; }
    .summary-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.4rem;
      color: var(--green);
      margin-bottom: 0.5rem;
    }
    .summary-stats {
      display: flex;
      justify-content: center;
      gap: 1.5rem;
      margin: 1rem 0;
    }
    .summary-stat {
      text-align: center;
    }
    .summary-stat-value {
      font-size: 1.5rem;
      font-weight: 700;
      color: var(--gold);
    }
    .summary-stat-label {
      font-size: 0.75rem;
      opacity: 0.7;
    }
    .summary-next {
      margin-top: 1rem;
      padding: 0.75rem 1.5rem;
      background: var(--green);
      color: white;
      border: none;
      border-radius: 8px;
      font-weight: 600;
      cursor: pointer;
      transition: all 0.2s;
    }
    .summary-next:hover { transform: scale(1.05); }

    /* Badge Progress Tooltip */
    .badge-progress {
      font-size: 0.55rem;
      color: rgba(255,255,255,0.4);
      position: absolute;
      bottom: -2px;
      right: -2px;
      background: var(--deep-navy);
      padding: 0 3px;
      border-radius: 3px;
    }
    .badge-item { position: relative; }

    /* Glossary Panel */
    .glossary-toggle {
      position: fixed;
      bottom: 1.5rem;
      right: 1.5rem;
      width: 50px;
      height: 50px;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 50%;
      font-size: 1.3rem;
      cursor: pointer;
      box-shadow: 0 4px 15px rgba(0,0,0,0.3);
      z-index: 500;
      transition: all 0.2s;
    }
    .glossary-toggle:hover { transform: scale(1.1); }
    .glossary-panel {
      position: fixed;
      bottom: 0;
      right: 0;
      width: 350px;
      max-height: 70vh;
      background: var(--deep-navy);
      border: 1px solid var(--gold);
      border-radius: 12px 0 0 0;
      transform: translateY(100%);
      transition: transform 0.3s ease;
      z-index: 501;
      display: flex;
      flex-direction: column;
    }
    .glossary-panel.open { transform: translateY(0); }
    .glossary-header {
      padding: 1rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      display: flex;
      justify-content: space-between;
      align-items: center;
    }
    .glossary-header h3 {
      font-family: 'Cormorant Garamond', serif;
      color: var(--gold);
      margin: 0;
    }
    .glossary-close {
      background: none;
      border: none;
      color: var(--cream);
      font-size: 1.2rem;
      cursor: pointer;
    }
    .glossary-content {
      flex: 1;
      overflow-y: auto;
      padding: 1rem;
    }
    .glossary-item {
      margin-bottom: 1rem;
      padding-bottom: 1rem;
      border-bottom: 1px solid rgba(255,255,255,0.1);
    }
    .glossary-term {
      font-weight: 700;
      color: var(--gold);
      font-size: 0.9rem;
    }
    .glossary-def {
      font-size: 0.8rem;
      color: rgba(255,255,255,0.8);
      margin-top: 0.25rem;
    }

    /* Streak Warning */
    .streak-warning {
      background: rgba(239,68,68,0.2);
      border: 1px solid var(--red);
      color: var(--red);
      animation: pulse-warning 2s infinite;
    }
    @keyframes pulse-warning {
      0%, 100% { opacity: 1; }
      50% { opacity: 0.6; }
    }

    /* Perfect Module Bonus */
    .perfect-bonus {
      background: linear-gradient(135deg, var(--gold), #fbbf24);
      color: var(--navy);
      padding: 0.5rem 1rem;
      border-radius: 20px;
      font-weight: 700;
      display: inline-flex;
      align-items: center;
      gap: 0.5rem;
      margin-top: 0.5rem;
      animation: shine 2s infinite;
    }
    @keyframes shine {
      0%, 100% { box-shadow: 0 0 10px rgba(212,175,55,0.5); }
      50% { box-shadow: 0 0 20px rgba(212,175,55,0.8); }
    }

    /* Focus States for Accessibility */
    .decision-option:focus,
    .quiz-option:focus,
    .predict-btn:focus,
    .btn:focus,
    .nav-btn:focus {
      outline: 2px solid var(--gold);
      outline-offset: 2px;
    }

    /* Print Stylesheet */
    @media print {
      .sidebar, .slide-nav, .stats-panel, .badges-panel, .glossary-toggle, .glossary-panel, .header-actions { display: none !important; }
      .main-content { width: 100%; }
      .slide { position: relative !important; page-break-inside: avoid; padding: 1rem; }
      .slide.active, .slide { opacity: 1 !important; visibility: visible !important; display: block !important; }
      .module-slides { display: block !important; }
    }

    /* Responsive */
    @media (max-width: 900px) {
      .sidebar { width: 70px; }
      .sidebar-header h1, .sidebar-header p, .module-title, .module-subtitle, .module-xp,
      .stats-panel, .badges-panel, .course-progress { display: none; }
      .module-item { padding: 0.6rem; justify-content: center; }
      .glossary-panel { width: 100%; border-radius: 12px 12px 0 0; }
      .progress-dot { width: 44px; height: 44px; }
      .progress-dot::after { width: 8px; height: 8px; }
      .progress-dot.active::after,
      .progress-dot.completed::after { width: 10px; height: 10px; }
    }

    /* Touch feedback */
    @media (hover: none) {
      .decision-option:active { background: rgba(124,58,237,0.3); }
      .quiz-option:active { background: rgba(212,175,55,0.2); }
    }

    /* Reduced motion support */
    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
      }
      .confetti { display: none; }
    }

    /* Skip to content link */
    .skip-link {
      position: absolute;
      top: -40px;
      left: 0;
      background: var(--gold);
      color: var(--navy);
      padding: 0.5rem 1rem;
      z-index: 10000;
      font-weight: 600;
      text-decoration: none;
      border-radius: 0 0 8px 0;
    }
    .skip-link:focus {
      top: 0;
    }

    /* Course completion modal */
    .completion-modal {
      position: fixed;
      top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.95);
      display: none;
      justify-content: center;
      align-items: center;
      z-index: 1002;
    }
    .completion-modal.show { display: flex; }
    .completion-content {
      background: linear-gradient(135deg, var(--deep-navy), #0a0f1a);
      border: 3px solid var(--gold);
      border-radius: 20px;
      padding: 2.5rem;
      text-align: center;
      max-width: 450px;
      animation: completion-pop 0.5s ease;
    }
    @keyframes completion-pop {
      0% { transform: scale(0.5); opacity: 0; }
      50% { transform: scale(1.05); }
      100% { transform: scale(1); opacity: 1; }
    }
    .completion-trophy { font-size: 5rem; margin-bottom: 1rem; }
    .completion-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 2rem;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .completion-subtitle { font-size: 1rem; opacity: 0.8; margin-bottom: 1.5rem; }
    .completion-stats {
      display: flex;
      justify-content: center;
      gap: 1.5rem;
      margin-bottom: 1.5rem;
    }
    .completion-stat { text-align: center; }
    .completion-stat-value {
      font-size: 1.8rem;
      font-weight: 700;
      color: var(--gold);
    }
    .completion-stat-label { font-size: 0.75rem; opacity: 0.7; }
    .completion-close {
      padding: 0.75rem 2rem;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 8px;
      font-weight: 700;
      font-size: 1rem;
      cursor: pointer;
    }

    /* Review mistakes button */
    .review-mistakes-btn {
      position: fixed;
      bottom: 1.5rem;
      left: 1.5rem;
      padding: 0.6rem 1rem;
      background: rgba(239,68,68,0.2);
      border: 1px solid var(--red);
      color: var(--red);
      border-radius: 8px;
      font-size: 0.8rem;
      cursor: pointer;
      z-index: 500;
      display: none;
    }
    .review-mistakes-btn.show { display: block; }
    .review-mistakes-btn:hover { background: rgba(239,68,68,0.3); }

    /* Review panel */
    .review-panel {
      position: fixed;
      top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.9);
      display: none;
      z-index: 1003;
      overflow-y: auto;
      padding: 2rem;
    }
    .review-panel.show { display: block; }
    .review-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 1.5rem;
      max-width: 700px;
      margin-left: auto;
      margin-right: auto;
    }
    .review-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.5rem;
      color: var(--red);
    }
    .review-close {
      background: none;
      border: 1px solid var(--cream);
      color: var(--cream);
      padding: 0.5rem 1rem;
      border-radius: 6px;
      cursor: pointer;
    }
    .review-item {
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(239,68,68,0.3);
      border-radius: 12px;
      padding: 1.25rem;
      margin-bottom: 1rem;
      max-width: 700px;
      margin-left: auto;
      margin-right: auto;
    }
    .review-module { font-size: 0.75rem; color: var(--gold); margin-bottom: 0.5rem; }
    .review-question { font-weight: 600; margin-bottom: 0.75rem; }
    .review-your-answer { color: var(--red); font-size: 0.9rem; margin-bottom: 0.5rem; }
    .review-correct-answer { color: var(--green); font-size: 0.9rem; margin-bottom: 0.75rem; }
    .review-explanation { font-size: 0.85rem; opacity: 0.8; padding: 0.75rem; background: rgba(0,0,0,0.2); border-radius: 6px; }
  </style>
</head>
<body>
<a class="skip-link" href="#main-content">Skip to content</a>
<div class="course-container">
<!-- SIDEBAR -->
<nav aria-label="Navegaci√≥n del curso" class="sidebar">
<div class="sidebar-header">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;">‚Üê Course Library</a>
<h1>META-SPRINT</h1>
<p>40 d√≠as para obtener evidencia confiable</p>
</div>
<!-- Course Progress -->
<div class="course-progress">
<div class="course-progress-label">
<span>Course Progress</span>
<span id="courseProgressPct">0%</span>
</div>
<div class="course-progress-bar">
<div class="course-progress-fill" id="courseProgressFill" style="width: 0%"></div>
</div>
</div>
<!-- Gamification Stats -->
<div class="stats-panel">
<div class="level-display">
<div aria-label="Level icon" class="level-badge" id="levelIcon" role="img">üìä</div>
<div class="level-info">
<div class="level-title" id="levelTitle">Novice Analyst</div>
<div class="level-subtitle">Level <span id="levelNum">1</span></div>
</div>
</div>
<div aria-label="XP progress" class="xp-bar" role="progressbar">
<div class="xp-fill" id="xpFill" style="width: 0%"></div>
</div>
<div class="xp-text"><span id="xpCurrent">0</span> / <span id="xpNeeded">100</span> XP</div>
<div class="quick-stats">
<div class="quick-stat">
<div class="quick-stat-value" id="correctCount">0</div>
<div class="quick-stat-label">Correct</div>
</div>
<div class="quick-stat">
<div class="quick-stat-value" id="decisionCount">0</div>
<div class="quick-stat-label">Decisions</div>
</div>
<div class="quick-stat">
<div class="quick-stat-value" id="predictCount">0</div>
<div class="quick-stat-label">Predictions</div>
</div>
</div>
</div>
<div class="module-list" id="moduleList" role="list"></div>
<!-- Badges -->
<div class="badges-panel">
<div class="badges-title">Achievements</div>
<div class="badges-grid" id="badgesGrid"></div>
</div>
</nav>
<!-- MAIN -->
<div class="main-content">
<div class="content-header">
<div class="breadcrumb">META-SPRINT / <span id="currentModule">Introduction</span></div>
<div class="header-actions">
<div class="streak-display" id="streakDisplay">
<span class="streak-flame">üî•</span>
<span class="streak-count" id="streakCount">0</span>
<span style="font-size:0.7rem;opacity:0.7">streak</span>
</div>
<button class="btn" onclick="resetProgress()">Reset</button>
<button class="btn primary" onclick="nextSlide()">Continue ‚Üí</button>
</div>
</div>
<div class="content-body">
<div class="slides-container" id="main-content"></div>
</div>
</div>
</div>
<!-- XP Popup -->
<div class="xp-popup" id="xpPopup">
<span class="xp-amount" id="xpAmount">+25</span>
    XP
  </div>
<!-- Badge Modal -->
<div aria-labelledby="badgeModalTitle" aria-modal="true" class="badge-modal" id="badgeModal" role="dialog">
<div class="badge-modal-content">
<div class="badge-modal-icon" id="badgeModalIcon">üèÜ</div>
<div class="badge-modal-title" id="badgeModalTitle">Badge Earned!</div>
<div class="badge-modal-desc" id="badgeModalDesc">Desbloqueaste un nuevo logro</div>
<button class="badge-modal-close" onclick="closeBadgeModal()">Awesome!</button>
</div>
</div>
<!-- Confetti Container -->
<div class="confetti-container" id="confettiContainer"></div>
<!-- Combo Counter -->
<div class="combo-display" id="comboDisplay">üî• <span id="comboCount">0</span>x Combo!</div>
<!-- Mobile Sidebar Toggle -->
<button aria-expanded="false" aria-label="Toggle menu" class="sidebar-toggle" onclick="toggleSidebar()">‚ò∞</button>
<div class="sidebar-overlay" id="sidebarOverlay" onclick="toggleSidebar()"></div>
<!-- Glossary Toggle -->
<button aria-label="Open glossary" class="glossary-toggle" onclick="toggleGlossary()" title="Quick Reference">üìñ</button>
<!-- Glossary Panel -->
<div aria-label="Glossary" class="glossary-panel" id="glossaryPanel" role="dialog">
<div class="glossary-header">
<h3>Quick Reference</h3>
<button aria-label="Close glossary" class="glossary-close" onclick="toggleGlossary()">√ó</button>
</div>
<div class="glossary-content">
<div class="glossary-item">
<div class="glossary-term">DoD (Definition of Done)</div>
<div class="glossary-def">Binary gate checklist. All items must pass before proceeding to next phase.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">PICOS</div>
<div class="glossary-def">Poblaci√≥n, intervenci√≥n, comparador, resultados, dise√±o del estudio: marco para preguntas de investigaci√≥n.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Provenance</div>
<div class="glossary-def">La pista de auditor√≠a que muestra exactamente de d√≥nde proviene un n√∫mero (por ejemplo, "Tabla 2, p.1234").</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Red-Team</div>
<div class="glossary-def">Daily adversarial checking by 2 rotating members to catch errors in extraction.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">CondGO</div>
<div class="glossary-def">Emergency protocol: 72 hours to fix a failed DoD gate or terminate with documented reasons.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Surrogate Outcome</div>
<div class="glossary-def">A measurable marker (e.g., cholesterol) used as proxy for patient-important outcomes (e.g., death).</div>
</div>
<div class="glossary-item">
<div class="glossary-term">FREEZE (Day 34)</div>
<div class="glossary-def">Bloqueo de alcance: no se pueden agregar nuevos estudios despu√©s de este punto.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">I¬≤ (I-squared)</div>
<div class="glossary-def">Heterogeneity statistic. Low &lt;30%, Moderate 30-60%, High &gt;60%.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Analysis Capsule</div>
<div class="glossary-def">Paquete reproducible completo: c√≥digo, datos, instrucciones. Cualquiera puede ejecutarlo y obtener resultados id√©nticos.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Consult Pack</div>
<div class="glossary-def">Documento estructurado con opciones, evidencia y compensaciones para la toma de decisiones en equipo.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">PROSPERO</div>
<div class="glossary-def">Registro internacional para protocolos de revisi√≥n sistem√°tica. Marca la hora de tus m√©todos preespecificados.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">PRISMA</div>
<div class="glossary-def">Directriz de informes para revisiones sistem√°ticas. Incluye el diagrama de flujo que muestra la selecci√≥n de estudios.</div>
</div>
</div>
</div>
 Modal de finalizaci√≥n del curso 
<div aria-label="Curso completado" class="completion-modal" id="completionModal" role="dialog">
<div class="completion-content">
<div class="completion-trophy">üèÜ</div>
<div class="completion-title">Course Complete!</div>
<div class="completion-subtitle">You've mastered the META-SPRINT methodology</div>
<div class="completion-stats">
<div class="completion-stat">
<div class="completion-stat-value" id="finalXP">0</div>
<div class="completion-stat-label">Total XP</div>
</div>
<div class="completion-stat">
<div class="completion-stat-value" id="finalCorrect">0</div>
<div class="completion-stat-label">Correct Answers</div>
</div>
<div class="completion-stat">
<div class="completion-stat-value" id="finalBadges">0</div>
<div class="completion-stat-label">Badges Earned</div>
</div>
</div>
<p style="font-size:0.9rem;opacity:0.7;margin-bottom:1rem">¬°Contin√∫e y produzca evidencia confiable!</p>
<div class="completion-actions" style="display: flex; gap: 0.5rem; justify-content: center; flex-wrap: wrap;">
<button class="btn primary" onclick="downloadCertificate()">Download Certificate</button>
<button class="completion-close" onclick="closeCompletionModal()">Continue</button>
</div>
</div>
</div>
 Bot√≥n de revisi√≥n de errores 
<button aria-label="Revisar respuestas incorrectas" class="review-mistakes-btn" id="reviewMistakesBtn" onclick="showReviewPanel()">
    üìù Review Mistakes
  </button>
<!-- Review Panel -->
<div aria-label="Revisar respuestas incorrectas" class="review-panel" id="reviewPanel" role="dialog">
<div class="review-header">
<div class="review-title">üìù Revise sus errores</div>
<button class="review-close" onclick="closeReviewPanel()">Close</button>
</div>
<div id="reviewContent"></div>
</div>
<script>
// ===== GAMIFICATION STATE =====
const DEFAULT_STATE = {
  xp: 0,
  level: 1,
  streak: 0,
  lastActive: null,
  correctAnswers: 0,
  decisionsCompleted: 0,
  predictionsCorrect: 0,
  predictionsTotal: 0,
  badges: [],
  completedModules: [],
  perfectModules: [],
  answeredQuestions: {},
  consecutiveCorrect: 0
};

// Safe localStorage with fallback
function safeGetStorage(key, fallback) {
  try {
    const item = localStorage.getItem(key);
    return item ? JSON.parse(item) : fallback;
  } catch (e) {
    console.warn('localStorage unavailable, using session storage');
    return fallback;
  }
}

function safeSetStorage(key, value) {
  try {
    localStorage.setItem(key, JSON.stringify(value));
  } catch (e) {
    console.warn('Could not save to localStorage');
  }
}

// Migration from old storage key to versioned key
(function migrateStorage() {
  try {
    const oldData = localStorage.getItem('metasprintGame');
    if (oldData && !localStorage.getItem('metasprintGame_v1')) {
      localStorage.setItem('metasprintGame_v1', oldData);
      localStorage.removeItem('metasprintGame');
    }
  } catch (e) {}
})();

let gameState = safeGetStorage('metasprintGame_v1', DEFAULT_STATE);

const LEVELS = [
  { level: 1, title: "Novice Analyst", icon: "üìä", xp: 0 },
  { level: 2, title: "Protocol Apprentice", icon: "üìã", xp: 100 },
  { level: 3, title: "Search Specialist", icon: "üîç", xp: 250 },
  { level: 4, title: "Extraction Expert", icon: "üìù", xp: 450 },
  { level: 5, title: "Analysis Adept", icon: "üìà", xp: 700 },
  { level: 6, title: "Quality Guardian", icon: "üõ°Ô∏è", xp: 1000 },
  { level: 7, title: "Evidence Master", icon: "üèÜ", xp: 1400 },
  { level: 8, title: "Meta-Analysis Sage", icon: "üëë", xp: 1900 }
];

const BADGES = [
  { id: "first_blood", icon: "üéØ", name: "First Blood", desc: "Responda su primera pregunta correctamente" },
  { id: "perfect_5", icon: "‚≠ê", name: "Five Star", desc: "Get 5 correct answers in a row" },
  { id: "decision_maker", icon: "‚öñÔ∏è", name: "Decision Maker", desc: "Completa 10 √°rboles de decisi√≥n" },
  { id: "oracle", icon: "üîÆ", name: "The Oracle", desc: "Predict 5 outcomes correctly" },
  { id: "protocol_pro", icon: "üìã", name: "Protocol Pro", desc: "Completa el m√≥dulo de la Fase A" },
  { id: "search_savant", icon: "üîç", name: "Search Savant", desc: "Completa el m√≥dulo de la Fase B" },
  { id: "data_detective", icon: "üïµÔ∏è", name: "Data Detective", desc: "Completa el m√≥dulo de la Fase C" },
  { id: "stats_wizard", icon: "üßô", name: "Stats Wizard", desc: "Completa la Fase D m√≥dulo" },
  { id: "finisher", icon: "üèÅ", name: "Finisher", desc: "Completa todo el curso" },
  { id: "streak_3", icon: "üî•", name: "On Fire", desc: "Maintain a 3-day streak" },
  { id: "streak_7", icon: "üí´", name: "Weekly Warrior", desc: "Maintain a 7-day streak" },
  { id: "colchicine_hero", icon: "üíä", name: "Colchicine Hero", desc: "Completa el estudio de caso" }
];

// ===== MODULES DATA =====
const MODULES = [
  {
    id: 1, title: "Why META-SPRINT?", subtitle: "El costo de las malas pruebas", xp: 150,
    slides: [
      { type: "title", theme: "dark", content: { title: "Why META-SPRINT?", subtitle: "El costo de equivocarse" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand why bad evidence causes real harm",
          "Aprende de la tragedia de CAST y Poldermans fraude",
          "Recognize surrogate outcome traps",
          "Understand what provenance verification means"
        ],
        tip: "Este m√≥dulo prepara el escenario para todo lo que sigue."
      }},
      { type: "prediction", theme: "dark", content: {
        icon: "üîÆ", title: "Haga su predicci√≥n",
        subtitle: "En la d√©cada de 1980, se desarrollaron medicamentos para suprimir los latidos card√≠acos irregulares (PVC) despu√©s de los ataques card√≠acos. Los medicamentos arreglaron con √©xito las lecturas de ECG. ¬øQu√© crees que pas√≥ con las tasas de mortalidad?",
        options: [
          { id: "benefit", label: "üíö Deaths decreased", text: "Las drogas salvaron vidas" },
          { id: "neutral", label: "‚ö™ No change", text: "Las muertes se mantuvieron igual" },
          { id: "harm", label: "‚ù§Ô∏è Deaths increased", text: "Las drogas causaron da√±o" }
        ],
        answer: "harm",
        xp: 30
      }},
      { type: "story", theme: "red-bg", content: {
        label: "La tragedia de CAST", title: "50,000 Deaths",
        text: "The drugs that 'fixed' the ECG <strong>tripled</strong> death rates. 50,000 Americans died from drugs that made their monitors look better.",
        followup: "Suppressing PVCs was a surrogate outcome‚Äîit looked like benefit but masked real harm."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìä", title: "Escenario: Lo impresionante N√∫meros",
        xp: 25,
        scenario: "Un nuevo medicamento para la diabetes muestra que reduce la HbA1c (marcador de az√∫car en sangre) en un 40% m√°s que el tratamiento est√°ndar. El fabricante quiere acelerar la aprobaci√≥n bas√°ndose en estos 'impresionantes datos de eficacia'.",
        question: "What should regulators demand?",
        options: [
          { letter: "A", text: "Approve it‚Äî40% better HbA1c is significant", correct: false },
          { letter: "B", text: "Require trials showing reduced heart attacks, strokes, or death", correct: true },
          { letter: "C", text: "Aprobar con monitoreo post-comercializaci√≥n", correct: false },
          { letter: "D", text: "Request larger HbA1c trials for confirmation", correct: false }
        ],
        feedback: {
          correct: "Correct! HbA1c is a surrogate like PVCs. The CAST tragedy taught us: surrogates can improve while patients die. Demand patient-important outcomes.",
          incorrect: "HbA1c is a surrogate marker. CAST showed us that 'fixing' lab values can mask fatal harm. Always demand patient-important outcomes: death, heart attack, stroke."
        }
      }},
      { type: "stats", theme: "dark", content: {
        title: "La escala de fallas de evidencia",
        stats: [
          { value: "50,000", label: "CAST drug deaths" },
          { value: "800,000", label: "Poldermans fraud deaths" },
          { value: "70%", label: "Studies unreproducible" }
        ],
        caption: "Estos no son desastres raros. Son resultados predecibles de procesos interrumpidos."
      }},
      { type: "story", theme: "dark", content: {
        label: "El c√°lculo de cuentas de Vioxx", title: "The Memo They Tried to Hide",
        text: "In 1996, Merck scientists discovered their painkiller Vioxx caused heart attacks. They wrote internal memos. They calculated the excess deaths. They did <strong>nothing</strong>. For eight years, doctors prescribed Vioxx while Merck executives debated how to spin the data.",
        followup: "When the truth emerged in 2004: 88,000 Americans had suffered heart attacks. 38,000 died. One internal email read: 'The cardiovascular events are clearly there.' They knew. They waited. People died."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìß", title: "Escenario: La se√±al interna",
        xp: 25,
        scenario: "Eres investigador en una compa√±√≠a farmac√©utica. Su an√°lisis muestra que su exitoso medicamento aumenta los eventos card√≠acos en un 31%. Su gerente sugiere 'esperar por m√°s datos' y 'explorar interpretaciones alternativas' antes de escalar.",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Espere m√°s datos como se sugiere", correct: false },
          { letter: "B", text: "Informe los hallazgos inmediatamente a la junta de seguridad", correct: true },
          { letter: "C", text: "Run alternative analyses to see if the signal disappears", correct: false },
          { letter: "D", text: "Document your concerns in an email but take no action", correct: false }
        ],
        feedback: {
          correct: "Correct! The Vioxx lesson: 'waiting for more data' while people die is a decision that kills. Safety signals require immediate escalation.",
          incorrect: "Cada d√≠a de retraso tiene un recuento de cad√°veres. Los memorandos internos de Vioxx demostraban que lo sab√≠an, pero \"esperar m√°s datos\" mat√≥ a 38.000 personas. Informe las se√±ales de seguridad de inmediato."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El enga√±o del Tamiflu", title: "¬£473 millones por datos ocultos",
        text: "In 2009, governments stockpiled Tamiflu for pandemic flu. The UK spent ¬£473 million. The evidence? Manufacturer-funded trials showing 'reduced complications.' The catch? Roche refused to release the full trial data for <strong>five years</strong>.",
        followup: "When researchers finally obtained the raw data, they found: No evidence Tamiflu reduced hospitalizations. No evidence it prevented complications. Half a billion pounds spent on a promise that couldn't be verified."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚ö†Ô∏è", title: "Escenario: Los datos de Poldermans",
        xp: 25,
        scenario: "Est√°s revisando un metan√°lisis y notas que un investigador contribuy√≥ con 15 de los 40 incluidos. estudios. Sus datos muestran resultados dram√°ticamente mejores que otros. Nadie ha verificado que existan sus datos sin procesar.",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Incluir todos los estudios: pasaron la revisi√≥n por pares", correct: false },
          { letter: "B", text: "Solicitar verificaci√≥n de procedencia para sus estudios", correct: true },
          { letter: "C", text: "Exclude his studies without explanation", correct: false },
          { letter: "D", text: "Promediar sus resultados con otros para reducir el impacto", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! La verificaci√≥n de procedencia pregunta: \"¬øPuedo rastrear este n√∫mero hasta su origen?\" El fraude de Poldermans mat√≥ a 800.000 personas porque nadie hizo esta pregunta.",
          incorrect: "Not quite. Peer review doesn't verify raw data exists. You need provenance‚Äîthe trail from number to source document."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El enga√±o de Theranos", title: "One Drop of Blood, Billions in Lies",
        text: "In 2003, a 19-year-old Stanford dropout named <strong>Elizabeth Holmes</strong> made a promise that captivated the world: revolutionary blood tests from a single drop. No more needles. No more vials. Investors poured in $700 million. Walgreens signed a deal to put Theranos machines in 8,200 stores. Holmes graced magazine covers. Her company was valued at $9 billion.",
        followup: "The technology never worked. Not once. Theranos ran patient samples on competitors' machines, then hid the results. When the lies unraveled in 2015, the damage was done: <strong>thousands of patients received incorrect diagnoses</strong>. Cancer missed. HIV false positives. Treatment decisions based on fabricated data. Holmes is now serving 11 years in federal prison. The lesson: extraordinary claims without verifiable evidence aren't innovation‚Äîthey're fraud."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "ü©∏", title: "Escenario: la tecnolog√≠a revolucionaria",
        xp: 25,
        scenario: "Una startup afirma que su IA puede detectar 50 c√°nceres a partir de una sola extracci√≥n de sangre con un 99% de precisi√≥n. Han recaudado 500 millones de d√≥lares. Abundan los respaldos de celebridades. Pero se niegan a publicar sus datos de validaci√≥n, alegando \"secretos comerciales\". Un sistema hospitalario quiere implementarlo de inmediato.",
        question: "What should the hospital demand before deployment?",
        options: [
          { letter: "A", text: "Conf√≠e en la aprobaci√≥n e implementaci√≥n de la FDA", correct: false },
          { letter: "B", text: "Require independent validation on their own patient population", correct: true },
          { letter: "C", text: "Comience con un peque√±o piloto basado en los datos de la empresa", correct: false },
          { letter: "D", text: "Espere publicaciones revisadas por pares", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Theranos obtuvo la aprobaci√≥n de la FDA para una prueba y minti√≥ sobre docenas de otras. La validaci√≥n independiente de SUS pacientes no es negociable. Los secretos comerciales que ocultan datos de validaci√≥n son se√±ales de alerta.",
          incorrect: "Theranos fooled Walgreens, investors, and patients. The lesson: no independent validation, no deployment. 'Trust us' is not evidence."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "La cat√°strofe del OxyContin", title: "La p√≠ldora que gener√≥ una epidemia",
        text: "In 1996, Purdue Pharma launched OxyContin with a bold claim: their new opioid was <strong>'less than 1% addictive.'</strong> They cited a brief letter to the editor in a 1980 New England Journal of Medicine‚Äîfive sentences about hospital patients, not outpatient prescriptions. Sales reps repeated the claim 500,000 times to doctors. Purdue spent $200 million marketing it as safe.",
        followup: "The Sackler family knew. Internal documents showed they tracked addiction reports. They knew their 12-hour pill was wearing off early, driving patients to take more. They did the math: more pills, more profit. By 2021: <strong>500,000 Americans dead from opioid overdoses</strong>. Purdue pleaded guilty to federal charges‚Äîtwice. The Sacklers paid $6 billion but admitted no personal wrongdoing. One misrepresented paragraph. Half a million graves."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üíä", title: "Escenario: la persecuci√≥n de las citaciones",
        xp: 25,
        scenario: "Un representante de drogas afirma que su nuevo analg√©sico tiene un \"riesgo m√≠nimo de adicci√≥n, demostrado en la literatura.' Te entregan una referencia. Descubres que es una carta de cinco frases dirigida al editor de 1980 que estudia a los pacientes hospitalizados, no a la poblaci√≥n ambulatoria que tratas.",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "It's in NEJM, so it's credible enough", correct: false },
          { letter: "B", text: "Demand RCTs with addiction as a pre-specified outcome in relevant populations", correct: true },
          { letter: "C", text: "Prescribe cautiously and monitor patients yourself", correct: false },
          { letter: "D", text: "Wait for colleagues to report problems first", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! La tragedia del OxyContin comenz√≥ con una carta de cinco frases tergiversada como prueba. Las cartas no son pruebas. Exija ensayos reales con resultados relevantes en poblaciones relevantes.",
          incorrect: "Purdue construy√≥ un imperio a partir de una carta de 5 frases. \"Est√° publicado\" no significa \"es evidencia\". La poblaci√≥n, el dise√±o y los resultados deben coincidir con su pregunta cl√≠nica."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El esc√°ndalo de Surgisphere", title: "La base de datos que nunca existi√≥",
        text: "In May 2020, the world was desperate for COVID-19 answers. Then <strong>The Lancet</strong> published a bombshell: hydroxychloroquine increased deaths in COVID patients. The study claimed data from 96,000 patients across 671 hospitals on six continents. The WHO halted trials. Countries banned the drug. The paper had one problem: <strong>the data was fabricated</strong>.",
        followup: "Surgisphere, a tiny company with 11 employees, claimed to have a global hospital database larger than any healthcare system on Earth. One employee was a science fiction author. Another was an adult content model. When journalists asked for verification, the company couldn't produce a single hospital contract. Both The Lancet and NEJM retracted their Surgisphere papers within weeks. During a pandemic, fabricated data hijacked global health policy. The peer reviewers never asked: 'Can we see proof this database exists?'"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üè•", title: "Scenario: The Impossibly Large Dataset",
        xp: 25,
        scenario: "Un art√≠culo pretende analizar 200.000 pacientes de 1.500 hospitales en 47 pa√≠ses, recopilados por una empresa de la que nunca ha o√≠do hablar con 6 empleados. Los resultados cambiar√≠an las pautas de tratamiento. Los revisores lo aprobaron.",
        question: "Antes de citar esto en su revisi√≥n sistem√°tica, ¬øqu√© debe verificar?",
        options: [
          { letter: "A", text: "Si est√° en una revista importante, la revisi√≥n por pares fue suficiente", correct: false },
          { letter: "B", text: "Comun√≠quese con la compa√±√≠a de datos y solicite documentaci√≥n de las asociaciones hospitalarias", correct: true },
          { letter: "C", text: "Check if other researchers have cited it positively", correct: false },
          { letter: "D", text: "Busque estad√≠sticas anomal√≠as en las tablas publicadas", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Surgisphere enga√±√≥ a The Lancet y NEJM durante una pandemia. La verificaci√≥n de procedencia (‚Äúprobar que estos datos existen‚Äù) lo habr√≠a detectado. Las revistas prestigiosas no son procedencia.",
          incorrect: "The Lancet y NEJM fueron enga√±ados. La revisi√≥n por pares no verifica que existan bases de datos. Antes de confiar en datos extraordinarios, verifique que la fuente pueda demostrar que es real."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El desastre del Fen-Phen", title: "Las p√≠ldoras diet√©ticas que destruyeron corazones",
        text: "In 1992, a researcher combined two FDA-approved drugs‚Äîfenfluramine and phentermine‚Äîfor weight loss. The combination was never tested together. The results seemed miraculous: patients lost weight effortlessly. Doctors prescribed it to <strong>6 million Americans</strong>. Weight loss clinics sprouted everywhere. Women's magazines celebrated the breakthrough.",
        followup: "Then the Mayo Clinic noticed something terrifying. Young, healthy women were developing a rare heart valve disease. One cardiologist saw 24 cases in a single year‚Äîhe'd seen only a handful in his entire career. The FDA investigated: <strong>30% of fen-phen users had abnormal heart valves</strong>. The combination was destroying hearts. By the time it was pulled in 1997, the damage was catastrophic. American Home Products paid $13 billion in settlements. The lesson: combining 'safe' drugs without testing the combination is not science‚Äîit's an uncontrolled experiment on patients."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üíî", title: "Escenario: la combinaci√≥n no autorizada",
        xp: 25,
        scenario: "Un colega le muestra impresionantes resultados de p√©rdida de peso de combinar dos medicamentos aprobados de una manera que nunca se prob√≥ en ensayos. \"Ambos est√°n aprobados por la FDA, por lo que la combinaci√≥n debe ser segura\". Quieren publicar una serie de casos y recomendar el protocolo.",
        question: "¬øCu√°l es el defecto cr√≠tico en este razonamiento?",
        options: [
          { letter: "A", text: "Las series de casos son demasiado peque√±as para su publicaci√≥n", correct: false },
          { letter: "B", text: "Drug interactions can create harms not present in either drug alone", correct: true },
          { letter: "C", text: "Off-label use requires special FDA permission", correct: false },
          { letter: "D", text: "Weight loss drugs are too controversial", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Fen-phen combin√≥ dos medicamentos \"seguros\" en una combinaci√≥n que destruye el coraz√≥n. Las interacciones medicamentosas no son predecibles a partir de perfiles individuales. Las combinaciones no probadas requieren sus propios ensayos.",
          incorrect: "La fenfluramina era \"segura\". La fentermina era \"segura\". Juntos, destruyeron las v√°lvulas card√≠acas en el 30% de los usuarios. Las combinaciones necesitan su propia evidencia: las suposiciones matan."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "La tragedia del DES", title: "La droga que persigui√≥ a tres generaciones",
        text: "In 1938, scientists synthesized DES‚Äîa synthetic estrogen. By 1941, doctors were prescribing it to pregnant women to prevent miscarriages. It seemed logical: estrogen supports pregnancy. <strong>5 million American women</strong> took it between 1940 and 1971. Nobody ran a controlled trial. Nobody tracked the babies.",
        followup: "In 1971, a physician noticed something impossible: <strong>young women in their teens and twenties were developing a rare vaginal cancer</strong> that typically struck women over 50. He traced it back: their mothers had all taken DES during pregnancy. The drug hadn't caused immediate harm‚Äîit had planted a time bomb in the womb. DES daughters had higher rates of infertility, miscarriage, and cancer. DES granddaughters‚Äîthe third generation‚Äîshowed elevated cancer risks too. One untested assumption. Three generations of harm. The first controlled trial of DES, run in 1953, showed it <strong>didn't even prevent miscarriages</strong>‚Äîthe original indication was worthless."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "ü§∞", title: "Escenario: el tratamiento l√≥gico",
        xp: 25,
        scenario: "Un tratamiento biol√≥gicamente plausible para las complicaciones del embarazo se ha utilizado durante 15 a√±os sin da√±os inmediatos evidentes. No existen ensayos controlados. Un colega dice: \"Lo hemos usado en miles de pacientes; si causara problemas, ya lo sabr√≠amos\".",
        question: "What critical assumption does this reasoning miss?",
        options: [
          { letter: "A", text: "15 years isn't long enough to judge safety", correct: false },
          { letter: "B", text: "Pregnancy exposures can cause harms that only appear decades later in offspring", correct: true },
          { letter: "C", text: "Observational experience is never valid", correct: false },
          { letter: "D", text: "Colleagues might be hiding adverse events", correct: false }
        ],
        feedback: {
          correct: "Correct! DES taught us the cruelest lesson: pregnancy exposures can cause cancers that appear 20-30 years later in children and grandchildren. 'No immediate harm' is not 'no harm.'",
          incorrect: "DES parec√≠a seguro durante 30 a√±os, hasta que sus hijas comenzaron a desarrollar c√°ncer cuando eran adolescentes. Algunos da√±os tardan d√©cadas en manifestarse. El seguimiento a largo plazo de la descendencia es esencial para las exposiciones durante el embarazo."
        }
      }},
      { type: "refrain", theme: "black", content: { text: "La mala evidencia mata. META-SPRINT existe para producir evidencia en la que pueda confiar." }},
      { type: "quiz", theme: "dark", content: {
        question: "Why did the CAST drugs increase deaths despite 'working' on ECGs?",
        options: [
          { text: "Las lecturas de ECG se midieron incorrectamente", correct: false },
          { text: "La supresi√≥n de las PVC fue un sustituto, no un resultado real", correct: true },
          { text: "Los tama√±os de muestra eran demasiado peque√±os", correct: false },
          { text: "Los medicamentos estaban contaminados", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Exactly. PVC suppression was a surrogate outcome‚Äîit looked like benefit but masked real harm.",
          incorrect: "Los medicamentos funcionaron exactamente como se esperaba en los ECG. El problema era que los ECG 'solucionados' no significaban salvar vidas."
        }
      }}
    ]
  },
  {
    id: 2, title: "El marco de 40 d√≠as", subtitle: "Five phases, five gates", xp: 120,
    slides: [
      { type: "title", theme: "dark", content: { title: "40 Days, 5 Gates", subtitle: "Un sprint estructurado hacia evidencia confiable" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Learn the five phases of META-SPRINT",
          "Understand Definition of Done (DoD) gates",
          "Conozca la estructura del equipo y el compromiso de tiempo diario"
        ],
        tip: "The framework overview - you'll learn each phase in detail later."
      }},
      { type: "timeline", theme: "dark", content: {
        title: "Los cinco Fases",
        items: [
          { days: "Days 1-3", title: "Phase A: Protocol", desc: "Bloquee su pregunta y sus m√©todos", phase: "a" },
          { days: "Days 4-10", title: "Phase B: Search", desc: "Buscar y filtrar literatura", phase: "b" },
          { days: "Days 11-28", title: "Phase C: Extraction", desc: "Extraer datos con verificaci√≥n", phase: "c" },
          { days: "Days 29-33", title: "Phase D: Analysis", desc: "Ejecutar y verificar an√°lisis", phase: "d" },
          { days: "Days 34-40", title: "Phase E: Submit", desc: "Write, audit, submit", phase: "e" }
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üö™", title: "Scenario: The 'Almost Done' Gate",
        xp: 25,
        scenario: "Es el d√≠a 3. Su equipo ha completado 7 de 8 elementos de la lista de verificaci√≥n del DoD-A. El elemento que falta: el registro del protocolo en PROSPERO est√° 'pendiente de revisi√≥n' (generalmente demora entre 24 y 48 horas).",
        question: "¬øDeber√≠a aprobar DoD-A?",
        options: [
          { letter: "A", text: "Yes‚Äî7/8 is close enough, proceed to search", correct: false },
          { letter: "B", text: "No‚Äîwait for registration before passing gate", correct: true },
          { letter: "C", text: "S√≠, reg√≠strese m√°s tarde y actualice el protocolo", correct: false },
          { letter: "D", text: "Skip registration‚Äîit's just bureaucracy", correct: false }
        ],
        feedback: {
          correct: "Correct! Gates are binary: pass or fail. 'Almost done' with protocol isn't done. Incomplete PICOS led to 50,000 CAST deaths.",
          incorrect: "Las puertas son binarias. Sin cr√©dito parcial. El registro marca sus promesas; sin √©l, no puede demostrar que no cambi√≥ los resultados despu√©s de ver los datos."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "Definition of Done (DoD)",
        subtitle: "Binary gates: Pass or Fail",
        text: "Cada fase termina con una puerta del Departamento de Defensa: una lista de verificaci√≥n que debe estar completa al 100%. Sin cr√©dito parcial. No 'casi terminado'.",
        highlight: "The CAST lesson: 'Almost done' with protocol isn't done."
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Las pautas que acabaron con", title: "800.000 muertes a causa de un estafador",
        text: "Durante a√±os, las pautas cl√≠nicas recomendaron betabloqueantes antes de la cirug√≠a para prevenir ataques card√≠acos. ¬øLa evidencia? En gran parte de Don Poldermans, el investigador que contribuy√≥ con 15 estudios al metan√°lisis. Sus datos mostraron beneficios dram√°ticos. Sus datos fueron fabricados.",
        followup: "When the fraud was discovered and his studies removed, the math changed. Beta-blockers didn't prevent heart attacks during surgery‚Äîthey caused them. Researchers calculated: following guidelines based on Poldermans' fraud may have killed <strong>800,000 patients</strong> over a decade. One man's lies. Global guidelines. Mass harm."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìã", title: "Escenario: El colaborador dominante",
        xp: 25,
        scenario: "Est√°s actualizando una gu√≠a cl√≠nica. Su revisi√≥n sistem√°tica incluye 40 estudios. Un investigador contribuy√≥ con 15 de ellos, y sus estudios muestran efectos dram√°ticamente mayores que los de todos los dem√°s. Su trabajo nunca ha sido replicado de forma independiente.",
        question: "What should the guideline committee do?",
        options: [
          { letter: "A", text: "Incluya todos los estudios: la revisi√≥n por pares garantiza la calidad", correct: false },
          { letter: "B", text: "Ejecute an√°lisis de sensibilidad con y sin sus estudios", correct: true },
          { letter: "C", text: "Exclude his studies as obvious outliers", correct: false },
          { letter: "D", text: "Weight his studies lower due to 'heterogeneity'", correct: false }
        ],
        feedback: {
          correct: "Correct! Sensitivity analysis would have shown Poldermans' outsized influence. When one researcher dominates a field, verify their work independently before basing guidelines on it.",
          incorrect: "The Poldermans lesson: one dominant contributor can corrupt an entire field. Sensitivity analysis (with/without their studies) reveals dangerous dependencies."
        }
      }},
      { type: "stats", theme: "light", content: {
        title: "Los n√∫meros META-SPRINT",
        stats: [
          { value: "40", label: "Days total" },
          { value: "5", label: "Quality gates" },
          { value: "12", label: "Team members" },
          { value: "2h", label: "Max daily work" }
        ]
      }},
      { type: "quiz", theme: "dark", content: {
        question: "What happens if a DoD gate fails?",
        options: [
          { text: "Puede continuar de todos modos con un advertencia", correct: false },
          { text: "You must fix all items before proceeding", correct: true },
          { text: "You skip to the next phase and return later", correct: false },
          { text: "El proyecto se cancela autom√°ticamente", correct: false }
        ],
        xp: 15,
        feedback: {
          correct: "Right! Gates are non-negotiable. All items must pass before moving forward.",
          incorrect: "Las puertas son binarias; no puede continuar hasta que se hayan completado todos los elementos. Esto evita que los errores se acumulen."
        }
      }}
    ]
  },
  {
    id: 3, title: "Phase A: Protocol", subtitle: "D√≠as 1-3: Bloquee sus promesas", xp: 180,
    slides: [
      { type: "title", theme: "purple-bg", content: { title: "Phase A: Protocol", subtitle: "D√≠as 1-3: Bloquee sus promesas antes de ver los datos" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand why protocol registration prevents outcome switching",
          "Learn to write unambiguous PICOS criteria",
          "Master the DoD-A checklist requirements",
          "Recognize the danger of surrogate outcomes"
        ],
        tip: "¬°Completa todos los escenarios de decisi√≥n para ganar la insignia Protocol Pro!"
      }},
      { type: "story", theme: "dark", content: {
        label: "El resultado Cambio de epidemia", title: "31% of Trials Cheat",
        text: "Un estudio de PLOS encontr√≥ que el 31% de los ensayos cambiaron sus resultados primarios entre el registro y la publicaci√≥n, siempre en direcciones que hicieron que los resultados se vieran mejor."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîÑ", title: "Escenario: El cambio tentador",
        xp: 25,
        scenario: "Su protocolo de metan√°lisis especificaba la \"mortalidad por todas las causas\" como el resultado primario. Despu√©s de la extracci√≥n, se encuentra que s√≥lo 4 estudios informan sobre mortalidad, pero 12 informan sobre \"eventos cardiovasculares\". Su asesor sugiere cambiar los resultados primarios 'ya que los datos lo respaldan mejor'.",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Switch to cardiovascular events‚Äîmore data is better", correct: false },
          { letter: "B", text: "Keep mortality as primary, add CV events as secondary", correct: true },
          { letter: "C", text: "Report both as co-primary outcomes", correct: false },
          { letter: "D", text: "Revise el protocolo y vuelva a registrarse antes de continuar", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! El protocolo te protege de ti mismo. El 31% de los ensayos cambian los resultados; as√≠ es como los ensayos negativos se vuelven \"positivos\". Mantenga su principal original.",
          incorrect: "Cambiar los resultados despu√©s de ver los datos es exactamente como el 31% de las pruebas hacen trampa. Tu protocolo es tu promesa. Los eventos CV pueden ser un an√°lisis secundario."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El Reversi√≥n de la TRH", title: "Two Million Women",
        text: "Durante cuarenta a√±os, los m√©dicos prescribieron terapia de reemplazo hormonal para prevenir enfermedades card√≠acas en mujeres menop√°usicas. Los estudios observacionales mostraron un 50% menos de ataques card√≠acos. Parec√≠a obvio. Estaba mal.",
        followup: "In 2002, the Women's Health Initiative RCT was stopped early. HRT <strong>increased</strong> heart attacks by 29%. Increased strokes by 41%. Increased breast cancer by 26%. Two million women had been taking a drug that harmed them, prescribed based on evidence that looked good but wasn't."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "Escenario: La tentaci√≥n observacional",
        xp: 25,
        scenario: "Est√°s escribiendo un protocolo para una revisi√≥n sistem√°tica de una nueva intervenci√≥n. 50 estudios observacionales muestran un beneficio espectacular. S√≥lo existen tres ECA peque√±os con resultados mixtos. Su equipo sugiere centrarse solo en estudios observacionales \"donde los datos son m√°s s√≥lidos\".",
        question: "¬øC√≥mo deber√≠a estructurar el protocolo?",
        options: [
          { letter: "A", text: "Include only observational studies‚Äîlarger sample sizes", correct: false },
          { letter: "B", text: "Analyze RCTs and observational separately, RCTs primary", correct: true },
          { letter: "C", text: "Agrupar ECA y estudios observacionales juntos", correct: false },
          { letter: "D", text: "Excluir los estudios observacionales por completo", correct: false }
        ],
        feedback: {
          correct: "Correct! HRT observational studies showed 50% benefit; the RCT showed 29% harm. Confounding bias in observational studies can create illusions. RCTs must be primary.",
          incorrect: "The HRT reversal: observational studies said 'benefit,' the RCT said 'harm.' Healthy women chose HRT‚Äîconfounding created an illusion. RCTs break confounding."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "La historia del estudio 329", title: "Ghostwritten Lies",
        text: "In 2001, SmithKline Beecham published Study 329: paroxetine was 'safe and effective' for adolescent depression. Doctors prescribed it to millions of teenagers. But the published paper was ghostwritten. The actual data showed something else entirely.",
        followup: "The raw data: paroxetine was <strong>no better than placebo</strong> for depression. Worse: it increased suicidal thinking in adolescents by 200%. The ghostwriters had cherry-picked outcomes, hidden adverse events, and turned failure into success. It took 14 years to get the truth published."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìã", title: "Escenario: El dilema del punto de tiempo",
        xp: 30,
        scenario: "You're writing the protocol for a colchicine meta-analysis. Trials report MACE at 30 days, 90 days, 1 year, and 3 years. Two team members disagree: one wants 'longest follow-up,' another wants 'fixed 1-year for all.'",
        question: "¬øCu√°l es el mejor enfoque?",
        options: [
          { letter: "A", text: "Use longest follow-up per trial (maximizes data)", correct: false },
          { letter: "B", text: "Use fixed 1-year for all (cleaner comparison)", correct: false },
          { letter: "C", text: "Write a specific rule: 'Longest ‚â•1 year, else longest available'", correct: true },
          { letter: "D", text: "Decide m√°s tarde cuando veas qu√© datos existen", correct: false }
        ],
        feedback: {
          correct: "¬°Excelente! Una regla espec√≠fica y preespecificada evita la ambig√ºedad. La opci√≥n C equilibra la maximizaci√≥n de los datos con la interpretabilidad.",
          incorrect: "Both A and B have merit, but they're still ambiguous. A specific rule like 'longest ‚â•1 year where available, else longest available' prevents disagreement during extraction."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-A Checklist",
        items: [
          "PICOS + inclusion/exclusion defined",
          "Primary outcome specified",
          "Timepoint rule documented",
          "Model choice (fixed/random)",
          "Sensitivity set defined",
          "Secondary outcomes labelled exploratory",
          "Protocol registered (PROSPERO/protocols.io)",
          "Signed by Integrator + non-integrator"
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "Escenario: La trampa sustituta",
        xp: 25,
        scenario: "Su asesor cl√≠nico sugiere utilizar la \"reducci√≥n del colesterol\" como resultado primario porque m√°s ensayos lo informan. Pero su pregunta original era sobre la \"muerte cardiovascular\".",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Switch to cholesterol‚Äîmore data is better", correct: false },
          { letter: "B", text: "Keep cardiovascular death as primary", correct: true },
          { letter: "C", text: "Use both as co-primary outcomes", correct: false },
          { letter: "D", text: "Add cholesterol as exploratory sensitivity", correct: false }
        ],
        feedback: {
          correct: "Correct! The CAST tragedy taught us: surrogate outcomes (like cholesterol) can mask real harm. Keep patient-important outcomes primary.",
          incorrect: "Cholesterol is a surrogate‚Äîit can improve while patients die (as in CAST). The Vioxx lesson: stick to patient-important outcomes."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El esc√°ndalo de Macchiarini", title: "The Surgeon Who Implanted Death",
        text: "Paolo Macchiarini was called a miracle worker. The Italian surgeon claimed he could grow synthetic tracheas and implant them in dying patients. <strong>The Lancet</strong> published his 'breakthroughs.' The Karolinska Institute‚Äîhome of the Nobel Prize‚Äîhired him. Patients flew from around the world seeking his revolutionary procedure.",
        followup: "One by one, his patients died. Of the eight who received his synthetic tracheas, <strong>seven died</strong>‚Äîmost within two years, suffocating as the plastic scaffolds disintegrated inside their throats. Karolinska's own doctors raised alarms. They were ignored. When a documentary exposed the truth, investigators found: falsified ethics approvals, fabricated patient outcomes, and co-authors who had never seen the data. The prestigious institute that awards the Nobel Prize had harbored a fraud who killed patients for fame. The Lancet retracted multiple papers. Macchiarini was convicted of assault. The lesson: prestige protects nothing. Only verification protects patients."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üèõÔ∏è", title: "Escenario: el prestigioso innovador",
        xp: 25,
        scenario: "Un c√©lebre cirujano de una instituci√≥n de fama mundial publica resultados revolucionarios en las principales revistas. Su t√©cnica podr√≠a salvar a miles. Los colegas j√≥venes expresan su preocupaci√≥n por los resultados de los pacientes, pero los altos directivos los descartan como celos. Un equipo de documentales solicita entrevistas.",
        question: "¬øQu√© debe hacer la instituci√≥n?",
        options: [
          { letter: "A", text: "Protect the surgeon's reputation‚Äîbad press harms everyone", correct: false },
          { letter: "B", text: "Immediately audit all patient outcomes with independent reviewers", correct: true },
          { letter: "C", text: "Wait for peer-reviewed rebuttals before acting", correct: false },
          { letter: "D", text: "Let the surgeon respond to critics in his own publications", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! El mayor fracaso de Karolinska fue ignorar las advertencias internas para proteger su prestigio. Las auditor√≠as de resultados independientes (no la gesti√≥n de la reputaci√≥n) protegen a los pacientes. Los colegas j√≥venes a menudo ven lo que los l√≠deres no ven.",
          incorrect: "El Instituto Karolinska prefiri√≥ la reputaci√≥n a los pacientes. Siete personas murieron. Cuando los expertos plantean inquietudes, realice una auditor√≠a de inmediato. El prestigio no es evidencia de seguridad."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El fraude de Hwang Woo-suk", title: "The Pride of a Nation, Built on Lies",
        text: "In 2004, South Korean scientist <strong>Hwang Woo-suk</strong> announced he had cloned human embryos and created patient-specific stem cells‚Äîa breakthrough that could cure Parkinson's, diabetes, and paralysis. He was a national hero. The government issued postage stamps in his honor. Schools taught his achievements. His papers in <strong>Science</strong> were celebrated as Nobel-worthy.",
        followup: "A junior researcher noticed the photos looked wrong. The same cells appeared in multiple images, supposedly from different experiments. When Science investigated, the fa√ßade crumbled: the breakthrough data was fabricated. Hwang had pressured junior researchers‚Äîmostly women‚Äîto donate eggs under ethically questionable conditions. He had fabricated results to meet impossible expectations. The 'cloned' stem cells never existed. South Korea's national pride evaporated overnight. Hwang was convicted of embezzlement and bioethics violations. He had spent $40 million in government funds on research that produced nothing but lies."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "Escenario: La prioridad nacional",
        xp: 25,
        scenario: "El principal cient√≠fico de su pa√≠s afirma haber realizado un avance revolucionario. El gobierno est√° financiando una expansi√≥n masiva. Los competidores internacionales est√°n compitiendo para replicar. Un miembro junior del laboratorio le dice en voz baja que los datos de la imagen parecen manipulados, pero teme represalias por hablar.",
        question: "What is the correct first step?",
        options: [
          { letter: "A", text: "Proteja la identidad del denunciante mientras solicita un an√°lisis de imagen independiente", correct: true },
          { letter: "B", text: "Confronte al cient√≠fico principal directamente con sus preocupaciones", correct: false },
          { letter: "C", text: "Wait for international labs to attempt replication", correct: false },
          { letter: "D", text: "Report to government funders immediately", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! El an√°lisis forense de im√°genes realizado por analistas independientes (sin exponer al denunciante) es el camino seguro. El fraude de Hwang fue detectado mediante an√°lisis de im√°genes. Los investigadores j√≥venes que hablan necesitan protecci√≥n.",
          incorrect: "La confrontaci√≥n directa pone en peligro a los denunciantes y permite la destrucci√≥n de pruebas. El fraude de Hwang fue detectado mediante un an√°lisis de im√°genes que mostraba c√©lulas duplicadas. An√°lisis forense independiente, luego escalada."
        }
      }},
      { type: "concept", theme: "light", content: {
        title: "La regla de las dos firmas",
        subtitle: "Why two people must sign",
        text: "The Poldermans fraud succeeded because one researcher controlled everything. Single points of authority enable fraud.",
        highlight: "Two signatures means two people verified."
      }},
      { type: "quiz", theme: "dark", content: {
        question: "Why must the protocol be registered BEFORE DoD-A passes?",
        options: [
          { text: "It's a journal requirement only", correct: false },
          { text: "Marca la hora de tus promesas antes de ver los datos", correct: true },
          { text: "Hace que la revisi√≥n parezca m√°s profesional", correct: false },
          { text: "It's optional for non-Cochrane reviews", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "¬°Exactamente! El registro crea una marca de tiempo. Sin √©l, no puede demostrar que no cambi√≥ los resultados despu√©s de ver qu√© funcion√≥.",
          incorrect: "El registro marca la hora con sus m√©todos preespecificados. El 31 % de los ensayos cambian los resultados; el registro demuestra que usted no lo hizo."
        }
      }}
    ]
  },
  {
    id: 4, title: "Phase B: Search", subtitle: "Days 4-10: Document everything", xp: 150,
    slides: [
      { type: "title", theme: "dark", content: { title: "Phase B: Search & Screen", subtitle: "Days 4-10: Systematic, documented, reproducible" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand why search strings must be saved verbatim",
          "Learn calibration requirements for dual screening",
          "Master PRISMA reporting requirements",
          "Know when exclusion reasons are required"
        ],
        tip: "¬°Completa este m√≥dulo para obtener la insignia Search Savant!"
      }},
      { type: "story", theme: "dark", content: {
        label: "La retractaci√≥n Cochrane", title: "Every Character Matters",
        text: "Una revisi√≥n Cochrane se retract√≥ cuando los auditores no pudieron reproducir la b√∫squeda. 'Usamos PubMed' no es un m√©todo."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üíæ", title: "Escenario: La b√∫squeda reconstruida",
        xp: 25,
        scenario: "You're at Day 8. A team member admits they didn't save the exact search string from last week‚Äîbut they 'remember most of it' and have reconstructed it. The search yielded 2,400 results then; the reconstructed search yields 2,380.",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Accept it‚Äî20 missing records won't matter", correct: false },
          { letter: "B", text: "Vuelva a ejecutar y documente la nueva b√∫squeda como la oficial", correct: true },
          { letter: "C", text: "Utilice la b√∫squeda reconstruida y an√≥tela en las limitaciones", correct: false },
          { letter: "D", text: "Contact the database to get search history", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Una b√∫squeda que no se puede reproducir no es evidencia. Documente la nueva b√∫squeda como oficial, observe la desviaci√≥n y proceda con m√©todos transparentes.",
          incorrect: "The Cochrane retraction: 'We used PubMed' isn't a method. You need the exact string, exact date, exact filters. Start fresh with documented methods."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Los ensayos enterrados", title: "¬øAd√≥nde fueron 74 estudios?",
        text: "En 2008, los investigadores buscaron todos los ensayos registrados sobre antidepresivos. Encontraron 74 ensayos. Luego buscaron publicaciones. S√≥lo se hab√≠an publicado 38. ¬øLos otros 36? Enterrado. Oculto. Desaparecido.",
        followup: "Every single buried trial showed negative results. Every published trial showed positive results. The published literature told doctors: 'Antidepressants work 94% of the time.' The truth: they worked 51% of the time. Half the evidence had simply vanished."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîé", title: "Escenario: Los registros faltantes",
        xp: 25,
        scenario: "Su b√∫squeda de literatura publicada encuentra 12 ensayos sobre un nuevo medicamento, todos positivos. Consulta los registros de ensayos y encuentra 8 ensayos registrados adicionales que nunca se publicaron. La compa√±√≠a dice que los ensayos no publicados tuvieron 'problemas de calidad de los datos'.",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Incluya solo los 12 ensayos publicados: tienen datos utilizables", correct: false },
          { letter: "B", text: "Solicite datos no publicados a los contactos del registro y a la FDA", correct: true },
          { letter: "C", text: "Note the 8 missing trials as a limitation", correct: false },
          { letter: "D", text: "Excluya el medicamento de su revisi√≥n debido a sesgo preocupaciones", correct: false }
        ],
        feedback: {
          correct: "Correct! The buried trials lesson: 48% of antidepressant data was hidden. Request unpublished data from registries, FDA, authors. Half the truth is a lie.",
          incorrect: "36 of 74 antidepressant trials were buried‚Äîall negative. Published-only evidence showed 94% efficacy; true efficacy was 51%. Always hunt for unpublished data."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El esc√°ndalo de la reboxetina", title: "El medicamento que nunca funcion√≥",
        text: "Reboxetine was approved in Europe for depression. Published trials showed it worked. Doctors prescribed it. Then researchers obtained the unpublished data. <strong>74% of the patient data had never been published.</strong>",
        followup: "Los datos ocultos mostraron: La reboxetina no era mejor que el placebo. Fue peor que otros antidepresivos. Tuvo m√°s efectos secundarios. Los pacientes sufrieron durante a√±os con un medicamento que los reguladores aprobaron bas√°ndose en evidencia cuidadosamente seleccionada."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîç", title: "Escenario: El desacuerdo en la evaluaci√≥n",
        xp: 25,
        scenario: "Sus dos evaluadores revisaron de forma independiente 50 t√≠tulos/res√∫menes para su calibraci√≥n. Estuvieron de acuerdo s√≥lo en 28 (56% de acuerdo). El objetivo es ‚â•80%.",
        question: "What should happen next?",
        options: [
          { letter: "A", text: "Proceed anyway‚Äî56% is acceptable for complex topics", correct: false },
          { letter: "B", text: "Discuss disagreements, revise criteria, re-calibrate on new 25", correct: true },
          { letter: "C", text: "Have a third person break all ties", correct: false },
          { letter: "D", text: "Switch to single-screener with random verification", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Un acuerdo bajo significa que sus criterios son ambiguos. Discuta, revise, repita hasta llegar a ‚â•80%.",
          incorrect: "56% de acuerdo significa que sus criterios son ambiguos. B√°sicamente est√°s examinando al azar. Discutir, revisar, recalibrar."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-B Checklist",
        items: [
          "Search strings saved verbatim",
          "Search dates + limits recorded",
          "M√©todo de decodificaci√≥n registrado",
          "Screening calibration (‚â•80%)",
          "PRISMA counts live",
          "Screening log exportable"
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìä", title: "Escenario: El rompecabezas PRISMA",
        xp: 25,
        scenario: "Your PRISMA shows: Identified: 2,400 | After dedup: 1,800 | Screened: 1,800 | Full-text: 150 | Included: 45. A peer reviewer asks: 'What happened to the 1,650 excluded at screening?'",
        question: "¬øCu√°l es la respuesta correcta?",
        options: [
          { letter: "A", text: "'They didn't meet criteria'‚Äîno need for details", correct: false },
          { letter: "B", text: "Provide counts by exclusion reason", correct: false },
          { letter: "C", text: "Explain that screening exclusions don't need reasons", correct: true },
          { letter: "D", text: "Go back and document each exclusion reason", correct: false }
        ],
        feedback: {
          correct: "Correct! Title/abstract screening exclusions don't require individual reasons (too many). Full-text exclusions DO need documented reasons.",
          incorrect: "Screening exclusions (title/abstract) don't require individual reasons‚Äîthere are too many. But FULL-TEXT exclusions must have documented reasons."
        }
      }},
      { type: "stats", theme: "dark", content: {
        title: "PRISMA Requirements",
        stats: [
          { value: "100%", label: "Numbers add up" },
          { value: "Every", label: "Full-text exclusion documented" },
          { value: "Zero", label: "Black boxes" }
        ]
      }},
      { type: "story", theme: "dark", content: {
        label: "Los desaparecidos La mitad", title: "Estudios secretos de Neurontin",
        text: "Pfizer promovi√≥ Neurontin para el trastorno bipolar, las migra√±as y el dolor; usos nunca aprobados por la FDA. Documentos internos revelaron que hab√≠an encargado estudios. Cuando los resultados fueron negativos, los estudios simplemente... desaparecieron.",
        followup: "La literatura publicada demostr√≥ que Neurontin funcion√≥ para usos no autorizados. La literatura no publicada demostr√≥ que no era as√≠. Los m√©dicos vieron s√≥lo la mitad de la evidencia y llegaron a una conclusi√≥n obvia (equivocada). Pfizer pag√≥ 430 millones de d√≥lares en multas. ¬øPero los pacientes que recibieron un tratamiento ineficaz? Pagaron m√°s."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìÅ", title: "Escenario: Oferta de la empresa",
        xp: 25,
        scenario: "Una empresa farmac√©utica ofrece compartir su 'base de datos interna completa' para su revisi√≥n sistem√°tica. Prometen todos los datos del ensayo, pero solo si usted firma un acuerdo de confidencialidad que le impide publicar los resultados de los ensayos individuales sin su aprobaci√≥n.",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Acepte: obtener los datos es lo que importa", correct: false },
          { letter: "B", text: "Acepte, pero tenga en cuenta la restricci√≥n en sus m√©todos", correct: false },
          { letter: "C", text: "Rechace y solicite datos a trav√©s de canales oficiales en su lugar", correct: true },
          { letter: "D", text: "Acepte esta revisi√≥n, luche por la transparencia m√°s tarde", correct: false }
        ],
        feedback: {
          correct: "Correct! Neurontin's lesson: companies hide what they don't want seen. Confidentiality agreements can be weaponized. Request data through FDA, EMA, or AllTrials instead.",
          incorrect: "El esc√°ndalo de Neurontin: las empresas suprimieron los ensayos negativos. Los acuerdos de confidencialidad les otorgan poder de veto sobre lo que usted informa. Mantenga la independencia."
        }
      }},
      { type: "quiz", theme: "dark", content: {
        question: "Why must search dates be recorded?",
        options: [
          { text: "Para los registros de la revista", correct: false },
          { text: "Las bases de datos se actualizan diariamente: su fecha es su marca de tiempo", correct: true },
          { text: "To calculate how long the search took", correct: false },
          { text: "It's optional metadata", correct: false }
        ],
        xp: 15,
        feedback: {
          correct: "¬°Exactamente! Una b√∫squeda el lunes encuentra estudios diferentes a los del martes. Tus fechas definen qu√© universo buscaste.",
          incorrect: "Las bases de datos se actualizan constantemente. Su fecha de b√∫squeda es la marca de tiempo del universo literario que busc√≥."
        }
      }}
    ]
  },
  {
    id: 5, title: "Phase C: Extraction", subtitle: "Days 11-28: Provenance for every number", xp: 200,
    slides: [
      { type: "title", theme: "dark", content: { title: "Phase C: Extraction", subtitle: "Days 11-28: Every number needs a source" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand what provenance means and why it matters",
          "Learn the Red-Team daily checking system",
          "Handle conflicting numbers with pre-specified rules",
          "Recognize the COLCOT near-disaster pattern"
        ],
        tip: "El estudio de caso COLCOT muestra c√≥mo un brazo intercambiado casi revierte las conclusiones."
      }},
      { type: "prediction", theme: "dark", content: {
        icon: "üîÆ", title: "El ensayo COLCOT",
        subtitle: "The largest trial (n=4,745) in a colchicine meta-analysis. The extractor pulls data from Figure 3 showing colchicine vs placebo events. Quick forest plot shows colchicine INCREASES events, while all other trials show benefit. What happened?",
        options: [
          { id: "benefit", label: "üìä Statistical fluke", text: "Random variation‚Äîinclude as-is" },
          { id: "neutral", label: "‚ùì Error de entrada de datos", text: "Wrong numbers typed" },
          { id: "harm", label: "üîÑ Arms swapped", text: "Intervention/control mixed up" }
        ],
        answer: "harm",
        xp: 30
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El COLCOT Casi desastre", title: "One Swapped Arm",
        text: "The extractor assumed left bar = intervention. It was right = intervention. One error in one critical field would have reversed the entire conclusion.",
        followup: "El control diario del Equipo Rojo detect√≥ esto. Por eso se verifican estudios influyentes."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¥", title: "Scenario: Red-Team Finds an Error",
        xp: 30,
        scenario: "La inspectora del equipo rojo, F√°tima, descubre que los brazos COLCOT est√°n intercambiados. Esta es la prueba m√°s grande (40% del peso total). El extractor defiende: 'La cifra era ambigua'.",
        question: "What should happen?",
        options: [
          { letter: "A", text: "Correcci√≥n con procedencia de la Tabla 2, correcci√≥n de registro", correct: true },
          { letter: "B", text: "Exclude COLCOT‚Äîtoo risky to include", correct: false },
          { letter: "C", text: "Expand audit to ALL studies immediately", correct: false },
          { letter: "D", text: "Ask the original authors to clarify", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Corrija con procedencia (la Tabla 2 confirma la asignaci√≥n), registre la correcci√≥n. El error de causa √∫nica y clara no requiere una auditor√≠a ampliada.",
          incorrect: "No excluya datos buenos ni ampl√≠e demasiado la auditor√≠a por un error de causa √∫nica y clara. Arr√©glelo con procedencia, reg√≠strelo e informe al extractor."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "El sistema del equipo rojo",
        subtitle: "Daily adversarial checking",
        text: "Todos los d√≠as desde el d√≠a 11, 2 miembros rotativos del equipo dedican entre 12 y 15 minutos a verificar los estudios seleccionados autom√°ticamente.",
        highlight: "La detecci√≥n de Boldt: su fraude (m√°s de 90 estudios) fue detectado cuando un El equipo rojo not√≥ tasas de reclutamiento imposibles."
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El desastre de Boldt", title: "Noventa estudios de mentiras",
        text: "Joachim Boldt fue el investigador m√°s prol√≠fico en anestesia. Public√≥ m√°s de 90 estudios sobre fluidos coloides. Su trabajo dio forma a las directrices cl√≠nicas en todo el mundo. Entonces alguien se dio cuenta: un hospital afirmaba reclutar a 800 pacientes en condiciones que solo afectaban a 200 pacientes por a√±o.",
        followup: "Investigation revealed: No ethics approval existed. Patient records couldn't be found. Co-authors had never seen the data. <strong>Ninety studies</strong> were retracted‚Äîthe largest fraud in medical history. Clinical guidelines had to be rewritten. The question that would have stopped him? 'Can you show me the source documents?'"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¢", title: "Escenario: Los n√∫meros imposibles",
        xp: 25,
        scenario: "Durante la extracci√≥n, observa que un estudio reclut√≥ a 450 pacientes con una condici√≥n rara de un solo hospital en 18 meses. La epidemiolog√≠a publicada sugiere que el hospital atiende alrededor de 50 pacientes de este tipo por a√±o.",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Incluya el estudio: el √©xito del reclutamiento var√≠a", correct: false },
          { letter: "B", text: "Marcar para verificaci√≥n: verifique la aprobaci√≥n √©tica y los registros de los pacientes", correct: true },
          { letter: "C", text: "Exclude as a statistical outlier", correct: false },
          { letter: "D", text: "Env√≠e un correo electr√≥nico a los autores para aclarar los m√©todos de reclutamiento", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Boldt fue atrapado porque las tasas de reclutamiento eran imposibles. Cuando los n√∫meros no tienen sentido, verifique que existan los documentos fuente antes de incluir el estudio.",
          incorrect: "As√≠ es como encontraron a Boldt: 800 pacientes con afecciones que afectaban a 200 por a√±o. Los n√∫meros imposibles indican un posible fraude. Verifique la aprobaci√≥n √©tica y existan datos sin procesar."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El fraude de Wakefield", title: "12 Children, 12 Million Harmed",
        text: "En 1998, Andrew Wakefield public√≥ un estudio de 12 ni√±os que relacionaban la vacuna MMR con el autismo. Las tasas de vacunaci√≥n se desplomaron. Regresaron los brotes de sarampi√≥n. Los ni√±os murieron por enfermedades prevenibles.",
        followup: "It took 12 years to prove the fraud. Wakefield had been paid ¬£435,643 by lawyers to produce evidence for lawsuits. He had manipulated data. He had undisclosed conflicts. But for a decade, his 12-patient study outweighed millions of patients in honest research. One fraudulent paper. Thousands of preventable infections."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìù", title: "Escenario: La procedencia perdida",
        xp: 25,
        scenario: "An extractor recorded 'events: 45/230' for a study but didn't note the source (table/figure/page). When you check the PDF, you find events reported in Table 2 (45/230), Figure 1 (42/228), and text (43/225).",
        question: "¬øCu√°l es la acci√≥n correcta?",
        options: [
          { letter: "A", text: "Use any number‚Äîthey're close enough", correct: false },
          { letter: "B", text: "Use the most conservative estimate (42/228)", correct: false },
          { letter: "C", text: "Contacte a los autores para aclarar", correct: false },
          { letter: "D", text: "Apply pre-specified hierarchy (e.g., Table > Figure > Text)", correct: true }
        ],
        feedback: {
          correct: "¬°Correcto! Su protocolo debe especificar una jerarqu√≠a para n√∫meros en conflicto. Apl√≠quelo de manera consistente y documente la fuente.",
          incorrect: "Necesita una regla preespecificada para esta situaci√≥n. \"M√°s conservador\" es una regla, pero deber√≠a estar en su protocolo. Sin procedencia, no se puede verificar nada."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-C Checklist",
        items: [
          "Extraction template frozen",
          "RoB tool + decision rules written",
          "Critical fields verified by second person",
          "Overlap rules applied",
          "Arbitration process operating"
        ]
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El fraude de la anestesia de Reuben", title: "The Most Prolific Faker in Medicine",
        text: "Scott Reuben was anesthesiology's rising star. Between 1996 and 2008, he published prolifically on postoperative pain management. His studies shaped how surgeons treated patients after operations. Drug companies funded his research. <strong>Pfizer paid him consulting fees</strong> while he published studies showing their drugs worked brilliantly.",
        followup: "In 2009, an anonymous tip led to investigation. Reuben hadn't just manipulated data‚Äî<strong>he had never enrolled a single patient</strong>. Studies claiming to follow hundreds of patients were pure invention. He fabricated everything: consent forms, patient records, outcomes. Twenty-one papers were retracted. Clinical guidelines based on his 'research' had to be rewritten. The patients who received treatment recommendations based on his fabrications? They were experiments in a trial that never happened, with no informed consent, following protocols invented by a liar."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üë§", title: "Escenario: el investigador prol√≠fico",
        xp: 25,
        scenario: "Observa que un investigador ha publicado 15 ensayos en su campo en 3 a√±os, m√°s de lo que cualquier departamento podr√≠a realizar de manera realista. Todos muestran resultados positivos para los medicamentos fabricados por sus patrocinadores. Ning√∫n otro centro ha replicado sus hallazgos. Su instituci√≥n nunca ha auditado sus datos.",
        question: "¬øQu√© debe hacer antes de incluir sus estudios en su revisi√≥n?",
        options: [
          { letter: "A", text: "Include them‚Äîthey're peer-reviewed and published", correct: false },
          { letter: "B", text: "Request verification of ethics approval and patient enrollment records", correct: true },
          { letter: "C", text: "Ejecute an√°lisis de sensibilidad con y sin sus estudios", correct: false },
          { letter: "D", text: "Weight his studies lower due to potential bias", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Reuben public√≥ 21 ensayos inventados durante 12 a√±os. Nadie comprob√≥ si exist√≠an pacientes. Solicite documentaci√≥n de la junta de √©tica y verificaci√≥n de inscripci√≥n: los fabricantes no pueden producirlos.",
          incorrect: "Scott Reuben invent√≥ 21 estudios con pacientes imaginarios. La revisi√≥n por pares no lo capt√≥. El an√°lisis de sensibilidad no detecta la fabricaci√≥n. Verifique que los pacientes existieran."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El enga√±o de VIGOR", title: "The Three Heart Attacks They Hid",
        text: "Merck knew Vioxx caused heart attacks. Their own trial‚ÄîVIGOR‚Äîshowed it clearly. But the published paper in the <strong>New England Journal of Medicine</strong> had a secret: Merck scientists had chosen a data cutoff date that excluded <strong>three additional heart attacks</strong> that occurred in the Vioxx group.",
        followup: "Those three heart attacks mattered. Including them would have changed the safety signal from 'possibly concerning' to 'clearly dangerous.' Instead, the published paper suggested the increased heart attacks might be because the comparison drug (naproxen) was protective‚Äînot because Vioxx was deadly. The NEJM editors only learned of the missing data years later. They published an 'expression of concern,' calling it 'inaccurate and incomplete.' By then, tens of thousands had suffered heart attacks. The data cutoff wasn't a scientific decision. It was a marketing decision disguised as methodology."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìÖ", title: "Escenario: El l√≠mite estrat√©gico",
        xp: 25,
        scenario: "Est√° extrayendo datos y observa que la fecha l√≠mite de datos de un ensayo fue 2 semanas antes de la fecha de finalizaci√≥n indicada del estudio. Los m√©todos no explican por qu√©. Los eventos que ocurren despu√©s del l√≠mite no se informan. El momento coincide convenientemente con el momento en que las se√±ales de seguridad se habr√≠an vuelto estad√≠sticamente significativas.",
        question: "¬øQu√© debe documentar y solicitar?",
        options: [
          { letter: "A", text: "Utilice los datos publicados; los autores eligieron su l√≠mite", correct: false },
          { letter: "B", text: "Note unexplained cutoff in Risk of Bias; request complete data from authors/FDA", correct: true },
          { letter: "C", text: "Excluya el estudio por informes incompletos", correct: false },
          { letter: "D", text: "Impute likely events based on trends before cutoff", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! El corte de VIGOR escondi√≥ tres infartos que lo cambiaron todo. Documente los l√≠mites inexplicables como alto riesgo de sesgo y busque activamente datos completos de los registros o de la FDA.",
          incorrect: "El l√≠mite VIGOR de Merck no fue una metodolog√≠a, sino un ocultamiento. Los l√≠mites inexplicables son se√±ales de alerta. Documente el riesgo y busque datos completos a trav√©s de canales oficiales."
        }
      }},
      { type: "quiz", theme: "dark", content: {
        question: "What is 'provenance' in META-SPRINT?",
        options: [
          { text: "El pa√≠s donde se realiz√≥ un estudio", correct: false },
          { text: "A citation showing where a number came from", correct: true },
          { text: "La fuente de financiaci√≥n de un ensayo", correct: false },
          { text: "La fecha en que se public√≥ un estudio", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Right! Provenance like 'Table 2, p.1234' creates an audit trail. No provenance = no trust.",
          incorrect: "Provenance means the exact source: 'Table 2, p.1234.' It's your evidence trail for every extracted number."
        }
      }},
      { type: "summary", theme: "green-bg", content: {
        summary: "You've mastered extraction fundamentals: provenance, Red-Team checking, and handling conflicting data. Next: making your analysis reproducible."
      }}
    ]
  },
  {
    id: 6, title: "Phase D: Analysis", subtitle: "D√≠as 29-33: Reproducible resultados", xp: 180,
    slides: [
      { type: "title", theme: "green-bg", content: { title: "Phase D: Analysis", subtitle: "Days 29-33: If you can't reproduce it, neither can anyone else" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand rerun equivalence tolerances",
          "Aprenda a manejar las discrepancias de an√°lisis",
          "Know how to document influential studies",
          "Domine el concepto de c√°psulas de an√°lisis"
        ],
        tip: "La reproducibilidad no es negociable. ¬°Complete esto para obtener la insignia del Asistente de estad√≠sticas!"
      }},
      { type: "stats", theme: "dark", content: {
        title: "La crisis de reproducibilidad",
        stats: [
          { value: "70%", label: "Failed to reproduce others" },
          { value: "50%", label: "Failed to reproduce self" }
        ],
        caption: "Nature (2016): Most researchers can't reproduce published findings."
      }},
      { type: "story", theme: "red-bg", content: {
        label: "La verificaci√≥n de la realidad de Amgen", title: "47 of 53 Failed",
        text: "En 2012, los cient√≠ficos de Amgen intentaron reproducir 53 estudios \"hist√≥ricos\" sobre el c√°ncer: art√≠culos que hab√≠an dado forma a la investigaci√≥n del c√°ncer, lanzaron ensayos cl√≠nicos y consumieron miles de millones en fondos. Trabajaron directamente con autores originales. Usaron los mismos m√©todos.",
        followup: "Result: <strong>47 of 53 studies could not be reproduced.</strong> 89% failure rate. Years of research built on foundations that didn't exist. Clinical trials started based on findings that weren't real. The cancer research community had been chasing phantoms."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "Escenario: El art√≠culo emblem√°tico",
        xp: 25,
        scenario: "Un estudio precl√≠nico 'hist√≥rico' de una revista importante forma la base para un nuevo tratamiento. Tres intentos de replicaci√≥n realizados por laboratorios independientes han fracasado. Los autores originales dicen que los replicadores \"carec√≠an de experiencia t√©cnica\". Nadie ha visto los datos originales sin procesar.",
        question: "¬øC√≥mo deben tratar las directrices esta evidencia?",
        options: [
          { letter: "A", text: "Trust the original‚Äîit's in a top journal", correct: false },
          { letter: "B", text: "Downgrade certainty until reproducibility is demonstrated", correct: true },
          { letter: "C", text: "Weight original and replications equally", correct: false },
          { letter: "D", text: "Wait for a fourth replication attempt", correct: false }
        ],
        feedback: {
          correct: "Correct! The Amgen lesson: 89% of landmark cancer studies couldn't be reproduced. If it can't be replicated, it's not evidence‚Äîit's a hypothesis.",
          incorrect: "47 de 53 estudios emblem√°ticos no lograron reproducirse. El prestigio de una revista no es igual a la verdad. Los hallazgos irreproducibles nunca deben formar la base de las pautas de tratamiento."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El esc√°ndalo de Duke", title: "El genio que nunca fue",
        text: "Anil Potti de la Universidad de Duke desarroll√≥ una prueba gen√≥mica para personalizar el tratamiento del c√°ncer. Sus art√≠culos fueron publicados en las principales revistas. Los ensayos cl√≠nicos incluyeron pacientes. Fue celebrado como un visionario.",
        followup: "Then two statisticians noticed: the data was impossible. Gene signatures were backwards. Spreadsheets had been manipulated. Potti had invented his credentials. Over 100 cancer patients had been enrolled in trials based on fraudulent science. Some received treatments that harmed them based on data that never existed."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîÑ", title: "Escenario: La repetici√≥n de la falta de coincidencia",
        xp: 30,
        scenario: "Audit 2: Two analysts independently rerun the analysis. Analyst A: I¬≤=34.2%. Analyst B: I¬≤=31.8%. The tolerance is 1%. Difference: 2.4%.",
        question: "What should happen?",
        options: [
          { letter: "A", text: "Promedia los resultados: ambos son razonables", correct: false },
          { letter: "B", text: "Use the more conservative estimate", correct: false },
          { letter: "C", text: "Line-by-line comparison to find the discrepancy", correct: true },
          { letter: "D", text: "Trigger CondGO (emergency mode)", correct: false }
        ],
        feedback: {
          correct: "Correct! Line-by-line comparison found one SE rounded to 2 decimals instead of 4. Fix the source, rerun, verify match.",
          incorrect: "No promedies ni aceptes la falta de coincidencia. Encuentre la fuente de la discrepancia. En este caso: un SE se redonde√≥ incorrectamente."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "Rerun Equivalence Tolerances",
        subtitle: "Two runs must match exactly",
        checkpoints: [
          { day: "Study count", event: "Exactly identical" },
          { day: "Effect sizes", event: "‚â§0.001 (log scale)" },
          { day: "Pooled effect", event: "‚â§0.001" },
          { day: "I¬≤ heterogeneity", event: "Within 1%" }
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìà", title: "Escenario: el estudio influyente",
        xp: 25,
        scenario: "El an√°lisis de dejar uno fuera muestra que eliminar el ensayo COLCOT cambia el RR agrupado de 0,65 (significativo) a 0,78 (a√∫n significativo). COLCOT aporta el 40% del peso.",
        question: "¬øQu√© debes documentar?",
        options: [
          { letter: "A", text: "Nothing‚Äîresult is still significant", correct: false },
          { letter: "B", text: "Document that COLCOT is influential but robust", correct: true },
          { letter: "C", text: "Exclude COLCOT as an outlier", correct: false },
          { letter: "D", text: "Downgrade certainty to VERY LOW", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Documente estudios influyentes y observe que las conclusiones son s√≥lidas. No excluya los buenos datos solo porque son influyentes.",
          incorrect: "Debe documentar estudios influyentes. En este caso, eliminar COLCOT cambia la magnitud pero no la direcci√≥n; ese es un hallazgo s√≥lido. No excluya los buenos datos."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-D Checklist",
        items: [
          "Capsule runs end-to-end",
          "Forest + heterogeneity outputs",
          "Sensitivity set executed",
          "Estudios influyentes documentados",
          "Audit 2 completed",
          "Rerun equivalence satisfied"
        ]
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El encubrimiento de BMP-2", title: "Paid Authors, Hidden Harms",
        text: "Medtronic pag√≥ 210 millones de d√≥lares a cirujanos que escribieron art√≠culos sobre su producto de crecimiento √≥seo BMP-2. Todos los art√≠culos publicados dec√≠an que era seguro y eficaz. Cada art√≠culo fue escrito por autores con v√≠nculos financieros no revelados. Ninguno inform√≥ los eventos adversos que Medtronic conoc√≠a.",
        followup: "When independent researchers obtained FDA adverse event reports, they found: <strong>10-50x higher complication rates</strong> than published papers claimed. Cancers. Sterility. Chronic pain. The published literature was a marketing document. The real evidence was in FDA files no one had read."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üí∞", title: "Escenario: Honorarios de consultor√≠a",
        xp: 25,
        scenario: "You're extracting data from 15 studies on a medical device. You notice all 15 lead authors have received consulting fees from the manufacturer. The amounts range from $50,000 to $500,000 per author. All 15 studies show benefit; no harms are reported.",
        question: "¬øQu√© deber√≠a documentar en su revisi√≥n?",
        options: [
          { letter: "A", text: "Nothing‚Äîdisclosed conflicts aren't bias", correct: false },
          { letter: "B", text: "Document conflicts and check FDA adverse event database", correct: true },
          { letter: "C", text: "Exclude all studies due to conflict of interest", correct: false },
          { letter: "D", text: "Run sensitivity analysis by funding source", correct: false }
        ],
        feedback: {
          correct: "Correct! BMP-2 lesson: all published papers hid harms that FDA reports revealed. Always cross-check industry-funded device/drug studies against regulatory databases.",
          incorrect: "The BMP-2 cover-up: $210M paid to authors who reported no harms; FDA data showed 10-50x higher complication rates. Industry conflicts require regulatory cross-checking."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El desastre de la cadera metal sobre metal", title: "Las articulaciones que envenenaron a los pacientes",
        text: "In the 2000s, device manufacturers promised a revolution: metal-on-metal hip implants that would last forever. DePuy's ASR hip was the flagship. <strong>93,000 patients</strong> worldwide received them. The company cited laboratory testing showing excellent wear characteristics. Surgeons believed the marketing.",
        followup: "Inside patients' bodies, reality was different. The metal surfaces ground against each other, releasing cobalt and chromium ions into tissues. Patients developed <strong>metallosis</strong>‚Äîmetal poisoning causing tissue death, bone destruction, and chronic pain. Some developed neurological symptoms as cobalt reached their brains. The failure rate reached <strong>40% at 5 years</strong>‚Äîcatastrophic for a device meant to last decades. DePuy had internal data showing problems but kept selling. When the hip was finally recalled in 2010, Johnson & Johnson paid $2.5 billion in settlements. The laboratory tests that 'proved' safety had never predicted what happens inside a living, moving human body."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "ü¶¥", title: "Escenario: la evidencia de laboratorio",
        xp: 25,
        scenario: "Un nuevo implante quir√∫rgico muestra excelentes resultados en pruebas de desgaste de laboratorio y estudios en animales. El fabricante quiere saltarse los ensayos en humanos a gran escala y salir directamente al mercado con vigilancia poscomercializaci√≥n. \"Las pruebas de banco demuestran que funciona\", argumentan.",
        question: "¬øCu√°l es el defecto cr√≠tico en este razonamiento?",
        options: [
          { letter: "A", text: "Animal studies should be longer before human use", correct: false },
          { letter: "B", text: "Laboratory conditions cannot replicate the biological environment inside patients", correct: true },
          { letter: "C", text: "Post-marketing surveillance is sufficient for rare harms", correct: false },
          { letter: "D", text: "Las pruebas de banco s√≥lo son v√°lidas para medicamentos, no para dispositivos", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Las caderas de metal sobre metal pasaron todas las pruebas de laboratorio y luego envenenaron a los pacientes con iones met√°licos que ning√∫n simulador predijo. El cuerpo no es un laboratorio. Las pruebas en humanos en condiciones reales son irremplazables.",
          incorrect: "Las pruebas de laboratorio de DePuy mostraron que la cadera durar√≠a para siempre. Dentro de los pacientes, destru√≠a tejido y liberaba iones met√°licos. Condiciones de laboratorio ‚â† realidad biol√≥gica. Es esencial realizar grandes ensayos en humanos con un seguimiento prolongado."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El desastre de Essure", title: "La anticoncepci√≥n permanente que destruy√≥ vidas",
        text: "Bayer's Essure promised women permanent contraception without surgery‚Äîtiny metal coils inserted through the cervix that would block the fallopian tubes. The <strong>FDA approved it based on 2 years of data from 518 women</strong>. What could go wrong with a simple, non-surgical procedure?",
        followup: "Thousands of women reported devices migrating through their bodies, perforating organs, causing chronic pain, autoimmune reactions, and‚Äîdevastatingly‚Äî<strong>unintended pregnancies, including ectopic pregnancies that can be fatal</strong>. Women needed hysterectomies to remove devices they'd been told were 'permanent solutions.' A Facebook group for Essure victims grew to over 30,000 members. The FDA eventually added a black box warning, then restricted sales. Bayer stopped selling it in 2018. The lesson: 2 years of follow-up in 518 women was never enough to detect rare complications from a permanent implant. Approval timelines should match device permanence."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚ö†Ô∏è", title: "Escenario: el dispositivo permanente",
        xp: 25,
        scenario: "Un dispositivo implantable permanente est√° buscando la aprobaci√≥n de la FDA bas√°ndose en un seguimiento de 3 a√±os en 600 pacientes. El dispositivo debe permanecer en los pacientes de por vida. A√∫n no se han informado eventos adversos graves. La empresa sostiene que esto demuestra seguridad a largo plazo.",
        question: "What should regulators require before approval?",
        options: [
          { letter: "A", text: "Post-marketing surveillance with mandatory reporting", correct: false },
          { letter: "B", text: "Follow-up duration proportional to intended implant life; registry with long-term tracking", correct: true },
          { letter: "C", text: "Approval is appropriate‚Äî3 years is standard for devices", correct: false },
          { letter: "D", text: "Additional laboratory durability testing", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Essure fue aprobado con datos de 2 a√±os para un dispositivo permanente. Las complicaciones surgieron a lo largo de los a√±os. Los implantes permanentes necesitan un seguimiento proporcional a su permanencia y registros obligatorios a largo plazo.",
          incorrect: "Los datos de 2 a√±os de Essure omitieron complicaciones que destruyeron la salud de las mujeres. Un dispositivo permanente necesita un seguimiento proporcionalmente largo. La vigilancia posterior a la comercializaci√≥n detecta los problemas demasiado tarde."
        }
      }},
      { type: "quiz", theme: "dark", content: {
        question: "¬øQu√© es una 'c√°psula de an√°lisis'?",
        options: [
          { text: "A summary of key findings", correct: false },
          { text: "C√≥digo + datos + instrucciones que cualquiera puede ejecutar", correct: true },
          { text: "La salida del diagrama de bosque", correct: false },
          { text: "Datos comprimidos archivo", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "¬°Exactamente! Una c√°psula es todo lo necesario para reproducir su an√°lisis. C√≥digo, datos, entorno: todo versionado.",
          incorrect: "A capsule is a complete reproducible package: code, data, instructions. Anyone can run it and get identical results."
        }
      }}
    ]
  },
  {
    id: 7, title: "Phase E & CondGO", subtitle: "Days 34-40: Ship or emergency", xp: 180,
    slides: [
      { type: "title", theme: "red-bg", content: { title: "Phase E: Submission", subtitle: "D√≠as 34-40: FREEZE y CondGO" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Comprenda FREEZE y por qu√© es esencial",
          "Learn when CondGO is triggered",
          "Know the three CondGO exit options",
          "Master the DoD-E final checklist"
        ],
        tip: "El protocolo de emergencia que evita que \"nos ocuparemos de ello m√°s tarde\" desastres."
      }},
      { type: "concept", theme: "dark", content: {
        title: "El FREEZE (D√≠a 34)",
        subtitle: "No hay nuevos estudios despu√©s de este punto",
        text: "Scope is locked. Only corrections to existing data allowed.",
        highlight: "El esc√°ndalo de BMP: La industria sigui√≥ 'encontrando' nuevos estudios que favorec√≠an su producto. La congelaci√≥n evita el desplazamiento del alcance del arma."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìö", title: "Scenario: New Study After Freeze",
        xp: 25,
        scenario: "Es el d√≠a 36. Un colega le env√≠a un ECA reci√©n publicado que se ajusta perfectamente a sus criterios. Es una prueba grande y de alta calidad.",
        question: "What do you do?",
        options: [
          { letter: "A", text: "Add it‚Äîquality evidence shouldn't be excluded", correct: false },
          { letter: "B", text: "Note it as a limitation, don't add", correct: true },
          { letter: "C", text: "Add it but run sensitivity with/without", correct: false },
          { letter: "D", text: "Request deadline extension to include it", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Despu√©s de la congelaci√≥n, tenga en cuenta los nuevos estudios como limitaciones. Agregarlos abre la puerta a la inclusi√≥n selectiva.",
          incorrect: "Congelar significa congelar. Agregar \"solo este buen estudio\" es exactamente c√≥mo el alcance corrompe las revisiones. Tenga en cuenta como limitaci√≥n."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "La l√≠nea de tiempo de Avandia", title: "Seven Years of Silence",
        text: "GSK vio se√±ales cardiovasculares en 2000. Eligieron 'observar y esperar' sin fecha l√≠mite. Siete a√±os despu√©s, el metan√°lisis de Nissen expuso el da√±o.",
        followup: "CondGO exists because 'we'll deal with it eventually' kills people."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚è∞", title: "Escenario: La revisi√≥n indefinida",
        xp: 25,
        scenario: "Su revisi√≥n sistem√°tica encontr√≥ una posible se√±al de seguridad: el medicamento X muestra un 28% m√°s de eventos card√≠acos en comparaci√≥n con el placebo. Su supervisor sugiere \"mantener el hallazgo interno hasta que recopilemos m√°s datos\" sin un cronograma espec√≠fico.",
        question: "¬øEn qu√© deber√≠a insistir?",
        options: [
          { letter: "A", text: "Agree‚Äîpremature publication could cause panic", correct: false },
          { letter: "B", text: "Set a fixed deadline: publish or escalate within 30 days", correct: true },
          { letter: "C", text: "Comparta primero con el fabricante del medicamento para obtener su opini√≥n", correct: false },
          { letter: "D", text: "Run additional analyses to confirm the signal", correct: false }
        ],
        feedback: {
          correct: "Correct! The Avandia lesson: 'watch and wait with no deadline' killed 83,000 people. CondGO principle: safety signals need hard deadlines, not open-ended deliberation.",
          incorrect: "GSK 'watched and waited' on Avandia for seven years. 83,000 heart attacks later, we learned: indefinite timelines kill. Set hard deadlines for safety decisions."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "La historia completa de Avandia", title: "La hoja de c√°lculo que Enterrado",
        text: "En 1999, el propio an√°lisis de GlaxoSmithKline mostr√≥ que Avandia aument√≥ los ataques card√≠acos en un 31%. Un estad√≠stico de una empresa cre√≥ una hoja de c√°lculo. Los ejecutivos lo vieron. Calcularon la responsabilidad. Siguieron vendiendo.",
        followup: "For seven years, Avandia remained a blockbuster drug. $3 billion per year in sales. The spreadsheet stayed hidden. When Steven Nissen published his meta-analysis in 2007, the world learned what GSK had known since 1999: Avandia caused an estimated <strong>83,000 heart attacks</strong>. The delay wasn't oversight‚Äîit was a decision."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìà", title: "Escenario: La decisi√≥n empresarial",
        xp: 25,
        scenario: "Su an√°lisis muestra que un medicamento aumenta los eventos adversos en un 25%. El medicamento genera 2 mil millones de d√≥lares en ingresos anuales. Legal calcula que posibles demandas podr√≠an costar 500 millones de d√≥lares. Un alto ejecutivo sugiere que 'las matem√°ticas favorecen las ventas continuas'.",
        question: "¬øCu√°l es la respuesta √©tica?",
        options: [
          { letter: "A", text: "Esta es una decisi√≥n comercial, no cient√≠fica", correct: false },
          { letter: "B", text: "Report the finding to regulators immediately", correct: true },
          { letter: "C", text: "Seek independent confirmation before acting", correct: false },
          { letter: "D", text: "Agregue advertencias a la etiqueta y contin√∫e con las ventas", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! La hoja de c√°lculo de Avandia mostr√≥ da√±os en 1999. GSK hizo los \"calculos\" y sigui√≥ vendiendo. La respuesta √©tica nunca tiene que ver con los ingresos, sino con la seguridad del paciente.",
          incorrect: "GSK calculated liability vs. revenue and chose sales. 83,000 heart attacks later: the 'business decision' was mass harm. Safety findings require immediate regulatory disclosure."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "La lecci√≥n de la talidomida", title: "10,000 Children",
        text: "En 1957, una empresa alemana comercializ√≥ la talidomida como una pastilla para dormir segura para mujeres embarazadas. \"No hay evidencia de da√±o\", dijeron. No hab√≠an buscado da√±o. No hab√≠an requerido pruebas. Lo hab√≠an asumido.",
        followup: "Within four years: 10,000 children born with severe limb deformities. Many more died before birth. One woman, Frances Kelsey at the FDA, had demanded proper evidence before approving it in America. She was called 'bureaucratic.' Her skepticism saved thousands of American children. Evidence isn't bureaucracy. Evidence is protection."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üö®", title: "Scenario: CondGO Trigger",
        xp: 30,
        scenario: "Day 33. DoD-D fails: Audit 2 found that reruns don't match within tolerance, and you can't identify the source of discrepancy after 4 hours.",
        question: "What happens now?",
        options: [
          { letter: "A", text: "Extender el plazo por una semana", correct: false },
          { letter: "B", text: "Trigger CondGO: 72 hours to fix or decide", correct: true },
          { letter: "C", text: "Enviar de todos modos con una nota sobre la discrepancia", correct: false },
          { letter: "D", text: "Abandonar el proyecto", correct: false }
        ],
        feedback: {
          correct: "Correct! CondGO gives exactly 72 hours to fix using allowed actions, or make a termination decision.",
          incorrect: "CondGO is triggered. 72 hours, bounded actions only. No extensions. Fix it or face the decision to stop."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "CondGO Rules",
        subtitle: "72 hours, bounded actions",
        allowed: ["Correct extraction errors", "Fix conversions", "Resolve overlaps", "Repair audit pack"],
        forbidden: ["New outcomes", "Post-hoc subgroups", "Nuevos estudios despu√©s de la congelaci√≥n"]
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-E Checklist",
        items: [
          "Lista de verificaci√≥n PRISMA completo",
          "Todos los ap√©ndices completos",
          "Two reruns equivalent",
          "Clinical Summary included",
          "Registro de desviaci√≥n completo",
          "GRADE assessment done",
          "Audit-Grade Index: 9/9"
        ]
      }},
      { type: "quiz", theme: "dark", content: {
        question: "¬øCu√°les son las opciones de salida de CondGO?",
        options: [
          { text: "Continue, Pause, or Restart", correct: false },
          { text: "Pass, Submit minimal, or Terminate", correct: true },
          { text: "Extend 24h, 48h, or 72h", correct: false },
          { text: "No hay salidas; debes arreglarlo", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Right! PASS (fixed), Submit minimal version, or Terminate with Failure Log. No middle ground.",
          incorrect: "CondGO has exactly three exits: fix it (PASS), submit minimal version, or terminate and archive with Failure Log."
        }
      }}
    ]
  },
  {
    id: 8, title: "Caso: Colchicina Revisi√≥n", subtitle: "4 crises, 0 failures", xp: 250,
    slides: [
      { type: "title", theme: "purple-bg", content: { title: "La revisi√≥n de la colchicina", subtitle: "Un sprint de 40 d√≠as con 4 crisis y 0 fracasos" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "See META-SPRINT in action through a real case",
          "Learn how each crisis was resolved",
          "Understand why the system worked",
          "Apply lessons to your own reviews"
        ],
        tip: "Este estudio de caso une todo. ¬°Gana la insignia de H√©roe de Colchicina!"
      }},
      { type: "stats", theme: "dark", content: {
        title: "The Question",
        subtitle: "Does colchicine reduce cardiac events after heart attack?",
        stats: [
          { value: "8", label: "RCTs" },
          { value: "11,774", label: "Patients" },
          { value: "40", label: "Days" },
          { value: "4", label: "Crises" }
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "1Ô∏è‚É£", title: "Crisis 1: El dilema del punto temporal",
        xp: 25,
        scenario: "Day 2. Trials report MACE at 30 days, 90 days, 1 year, 3 years. Protocol says 'longest follow-up' but reviewers disagree on interpretation.",
        question: "¬øC√≥mo resolver√≠as esto?",
        options: [
          { letter: "A", text: "Vote on which interpretation to use", correct: false },
          { letter: "B", text: "Preparar paquete de consulta con opciones y compensaciones", correct: true },
          { letter: "C", text: "Let the Integrator decide alone", correct: false },
          { letter: "D", text: "Use both interpretations as sensitivity", correct: false }
        ],
        feedback: {
          correct: "Correct! The Consult Pack forces structured thinking. They chose: 'Longest ‚â•1 year, else longest available.'",
          incorrect: "Se prepar√≥ un paquete de consulta con evidencia y opciones. 15 minutos de discusi√≥n estructurada evitaron horas de reelaboraci√≥n."
        }
      }},
      { type: "decision", theme: "red-bg", content: {
        icon: "2Ô∏è‚É£", title: "Crisis 2: Los brazos intercambiados",
        xp: 30,
        scenario: "Day 14. Red-team pulls COLCOT (n=4,745). Forest plot shows colchicine INCREASES events‚Äîopposite of all other trials. Investigation reveals: Figure 3 bars were unlabeled, extractor assumed wrong direction.",
        question: "¬øQu√© salv√≥ esta revisi√≥n?",
        options: [
          { letter: "A", text: "La intuici√≥n del integrador", correct: false },
          { letter: "B", text: "El equipo rojo diario microverificaci√≥n", correct: true },
          { letter: "C", text: "Revisi√≥n por pares antes de la publicaci√≥n", correct: false },
          { letter: "D", text: "Statistical outlier detection", correct: false }
        ],
        feedback: {
          correct: "¬°Exactamente! El sistema Red-Team capt√≥ lo que la revisi√≥n colaborativa habr√≠a pasado por alto. Los estudios influyentes reciben controles contradictorios.",
          incorrect: "El control diario del Equipo Rojo detect√≥ esto. Fatima not√≥ que la direcci√≥n de COLCOT era opuesta: imposible si el medicamento realmente funcionara de manera diferente en un ensayo."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "3Ô∏è‚É£", title: "Crisis 3: La idea post-hoc",
        xp: 25,
        scenario: "Day 22. Clinical advisor suggests: 'Three trials used 0.5mg, five used 1mg. Shouldn't you analyze by dose?' He's probably right scientifically.",
        question: "¬øCu√°l es la respuesta correcta?",
        options: [
          { letter: "A", text: "Change primary analysis to split by dose", correct: false },
          { letter: "B", text: "Ignore the suggestion‚Äîtoo late to change", correct: false },
          { letter: "C", text: "Add as exploratory sensitivity, label post-hoc", correct: true },
          { letter: "D", text: "Regrese y agregue dosis al protocolo", correct: false }
        ],
        feedback: {
          correct: "Perfect! Good ideas after Day 3 go in sensitivity, clearly labelled post-hoc. Primary analysis stays protected.",
          incorrect: "El protocolo lo protege de usted mismo. Agr√©guelo como an√°lisis de SENSIBILIDAD, etiqu√©telo como 'exploratorio, post-hoc'."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "4Ô∏è‚É£", title: "Crisis 4: La falta de coincidencia en la repetici√≥n",
        xp: 25,
        scenario: "Day 31. Audit 2 reruns: Analyst A gets I¬≤=34.2%, Analyst B gets I¬≤=31.8%. Tolerance is 1%. Difference: 2.4%.",
        question: "¬øCu√°l fue la causa ra√≠z?",
        options: [
          { letter: "A", text: "Different software versions", correct: false },
          { letter: "B", text: "One SE rounded to 2 decimals instead of 4", correct: true },
          { letter: "C", text: "Different random seeds", correct: false },
          { letter: "D", text: "Error tipogr√°fico en la inclusi√≥n del estudio", correct: false }
        ],
        feedback: {
          correct: "Right! Line-by-line found Nidorf 2020 SE: 0.0847 vs 0.08. A 0.0047 difference created 2.4% I¬≤ change.",
          incorrect: "Line-by-line comparison found one SE was rounded to 2 decimals (0.08) instead of 4 (0.0847). 'Close enough' isn't."
        }
      }},
      { type: "stats", theme: "green-bg", content: {
        title: "The Result",
        stats: [
          { value: "RR 0.65", label: "95% CI: 0.49‚Äì0.88" },
          { value: "I¬≤ 34%", label: "Low-moderate" },
          { value: "9/9", label: "Audit-Grade" }
        ],
        caption: "Colchicine reduces major cardiac events by ~35%. The system caught all 4 crises."
      }},
      { type: "lesson", theme: "dark", content: {
        title: "Por qu√© el sistema Funcion√≥",
        lessons: [
          { title: "Crisis 1 ‚Üí Consult Pack", desc: "Structured discussion prevented rework" },
          { title: "Crisis 2 ‚Üí Red-Team", desc: "Adversarial checking caught the swap" },
          { title: "Crisis 3 ‚Üí Deviation Log", desc: "Good ideas captured safely" },
          { title: "Crisis 4 ‚Üí Rerun Tolerance", desc: "Precision requirements caught silent errors" }
        ]
      }},
      { type: "story", theme: "dark", content: {
        label: "El ensayo VIGOR", title: "Los ataques card√≠acos perdidos",
        text: "In 2000, Merck published the VIGOR trial for Vioxx. The paper showed a 4-fold increase in heart attacks compared to naproxen. But here's what they didn't tell you: three more heart attacks occurred <strong>after the data cutoff</strong>. Merck scientists knew about them. They didn't include them.",
        followup: "Why did it matter? Including those three heart attacks would have changed the risk ratio from concerning to alarming. Instead, the published paper suggested the difference might be because naproxen protected hearts‚Äînot because Vioxx damaged them. The data cutoff date was a decision. That decision cost lives."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚úÇÔ∏è", title: "Escenario: el l√≠mite conveniente",
        xp: 25,
        scenario: "Est√°s extrayendo datos de una prueba. El protocolo especificaba un seguimiento de hasta 12 meses. El art√≠culo publicado informa √∫nicamente datos de 6 meses. Una nota al pie dice \"ocurrieron eventos adicionales despu√©s de 6 meses pero no se incluyeron en el an√°lisis principal\".",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Utilice los datos de 6 meses tal como se publicaron", correct: false },
          { letter: "B", text: "Contacte a los autores para obtener datos de seguimiento completos", correct: true },
          { letter: "C", text: "Excluir el estudio debido a informes selectivos", correct: false },
          { letter: "D", text: "Nota la discrepancia en su evaluaci√≥n del riesgo de sesgo", correct: false }
        ],
        feedback: {
          correct: "Correct! The VIGOR lesson: data cutoffs can hide safety signals. Three missing heart attacks changed Vioxx from 'concerning' to 'alarming.' Always seek complete data.",
          incorrect: "El ensayo VIGOR excluy√≥ los ataques card√≠acos posteriores al l√≠mite que habr√≠an cambiado las conclusiones. Los cortes convenientes pueden ocultar se√±ales de seguridad cr√≠ticas. Obtenga datos completos."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "La tragedia de la prueba hormonal", title: "Primodos y los ni√±os que da√±√≥",
        text: "In the 1960s and 70s, doctors prescribed <strong>Primodos</strong>‚Äîa high-dose hormone pill‚Äîas a pregnancy test. Take two pills; if you bleed, you're not pregnant. Simple. Convenient. Millions of women used it. <strong>No one ran trials to check if it harmed unborn babies.</strong>",
        followup: "Then the birth defects appeared. Cleft palates. Heart malformations. Limb abnormalities. Women who had taken Primodos and were actually pregnant‚Äîthe test had failed‚Äîgave birth to damaged children. Decades later, researchers analyzed the data: exposure to Primodos was associated with a <strong>40% increase in congenital abnormalities</strong>. The manufacturer had received reports of problems for years. They kept selling. An official UK review in 2017 found 'clear evidence' of an association. The lesson: 'it seems to work' is not evidence. 'It seems safe' is not safety data. Pregnancy exposures demand the highest burden of proof."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üß™", title: "Escenario: la prueba conveniente",
        xp: 25,
        scenario: "Una nueva prueba de embarazo casera utiliza una nueva sustancia qu√≠mica que proporciona resultados en segundos en lugar de minutos. Ha sido utilizado por millones sin da√±os graves aparentes. Sin embargo, algunas mujeres realizan pruebas lo suficientemente temprano como para que la sustancia qu√≠mica pueda afectar los embriones en desarrollo en aquellas que realmente est√°n embarazadas.",
        question: "What evidence should exist before widespread marketing?",
        options: [
          { letter: "A", text: "Absence of reported harms is sufficient for a diagnostic test", correct: false },
          { letter: "B", text: "Long-term follow-up of pregnancy outcomes in exposed women vs. controls", correct: true },
          { letter: "C", text: "Los estudios de teratolog√≠a en animales son suficientes para exposiciones breves", correct: false },
          { letter: "D", text: "Post-marketing surveillance will detect any problems", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Los da√±os de Primodos no se detectaron durante d√©cadas porque nadie segu√≠a los resultados del embarazo. Cualquier exposici√≥n durante un posible embarazo necesita un seguimiento sistem√°tico de los resultados, no una vigilancia pasiva.",
          incorrect: "Primodos da√±√≥ a los beb√©s durante a√±os mientras 'nadie se daba cuenta'. Las exposiciones durante el embarazo necesitan un seguimiento proactivo de los resultados. La vigilancia poscomercializaci√≥n falla en el caso de defectos cong√©nitos; la conexi√≥n es dif√≠cil de probar m√°s adelante."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "La cat√°strofe de Baycol", title: "La estatina que disolvi√≥ los m√∫sculos",
        text: "In 1997, Bayer launched cerivastatin (Baycol) to compete in the lucrative statin market. It was the most potent statin ever‚Äîlowering cholesterol more effectively than competitors. Bayer pushed aggressive dosing. They promoted combining it with gemfibrozil for even greater cholesterol reduction. Sales reached $500 million annually.",
        followup: "Patients started dying. Their muscles were dissolving‚Äîa condition called <strong>rhabdomyolysis</strong>. Breakdown products overwhelmed kidneys. By the time Bayer withdrew Baycol in 2001, at least <strong>100 patients had died and over 1,500 were hospitalized</strong>. Internal documents revealed Bayer knew the risk was higher than competitors. They knew the gemfibrozil combination was especially dangerous. They kept promoting both. The 'most effective' statin became the deadliest. More aggressive isn't always better‚Äîsometimes it's fatal."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìà", title: "Escenario: el enfoque agresivo",
        xp: 25,
        scenario: "Un nuevo medicamento muestra efectos m√°s poderosos que tratamientos existentes a dosis m√°s altas. El fabricante quiere comercializar como est√°ndar la dosis efectiva m√°s alta. Los competidores utilizan dosis m√°s bajas con buenos perfiles de seguridad. Algunos informes iniciales mencionan eventos adversos graves relacionados con los m√∫sculos.",
        question: "What should guide dosing recommendations?",
        options: [
          { letter: "A", text: "Maximum efficacy should be the goal‚Äîthat's why patients take medication", correct: false },
          { letter: "B", text: "Lowest effective dose with systematic safety monitoring; investigate all serious events", correct: true },
          { letter: "C", text: "Match competitor dosing for market positioning", correct: false },
          { letter: "D", text: "Let prescribers choose based on patient cholesterol levels", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Las dosis agresivas de Baycol mataron a los pacientes. Los eventos musculares fueron se√±ales de advertencia. La dosis eficaz m√°s segura (no la m√°s potente) deber√≠a ser la est√°ndar. Los primeros acontecimientos graves exigen una investigaci√≥n, no un despido.",
          incorrect: "Baycol era la estatina \"m√°s potente\" y la m√°s mort√≠fera. M√°s no es mejor cuando el margen entre eficacia y toxicidad se estrecha. Los primeros eventos adversos graves son se√±ales, no ruido."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El casi accidente", title: "What If We Hadn't Checked?",
        text: "In the colchicine review, COLCOT contributed 40% of the total weight. If the swapped arms had gone undetected, the meta-analysis would have concluded: <strong>'Colchicine appears to INCREASE cardiac events.'</strong> The opposite of reality.",
        followup: "Es posible que los m√©dicos hayan ocultado un tratamiento eficaz. A los pacientes que podr√≠an haber sido ayudados se les habr√≠a negado. Un error de extracci√≥n, no detectado, podr√≠a haber revertido la pr√°ctica cl√≠nica. El control del Equipo Rojo dur√≥ 15 minutos. ¬øEl costo de perderlo? Incalculable."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚öñÔ∏è", title: "Escenario: La pregunta de 15 minutos",
        xp: 25,
        scenario: "Tu equipo est√° retrasado. La prueba m√°s grande (45% del peso total) no ha sido verificada por el Equipo Rojo. Alguien sugiere omitirlo \"porque la extracci√≥n la realiz√≥ nuestra persona m√°s experimentada\".",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Skip it‚Äîexperience reduces error rates", correct: false },
          { letter: "B", text: "Verify it‚Äîinfluential studies always get checked", correct: true },
          { letter: "C", text: "Spot-check one data point instead of full verification", correct: false },
          { letter: "D", text: "Trust but add a note about limited verification time", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! El casi error de la colchicina: 15 minutos de verificaci√≥n del Equipo Rojo detectaron un error que habr√≠a revertido las conclusiones. La experiencia no elimina los errores, la verificaci√≥n s√≠.",
          incorrect: "El error COLCOT fue cometido por un extractor experimentado. El control del Equipo Rojo dur√≥ 15 minutos. Saltarse la verificaci√≥n de estudios influyentes corre el riesgo de cometer errores catastr√≥ficos."
        }
      }}
    ]
  },
  {
    id: 9, title: "Final Assessment", subtitle: "Demuestra tu dominio", xp: 300,
    slides: [
      { type: "title", theme: "dark", content: { title: "Final Assessment", subtitle: "Apply everything you've learned" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Apply META-SPRINT principles to complex scenarios",
          "Demonstrate understanding of protocol integrity",
          "Handle crisis situations correctly",
          "Uphold ethical reporting standards"
        ],
        tip: "Tres escenarios desafiantes. ¬°Responda todo correctamente para obtener el bono de m√≥dulo perfecto!"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üéØ", title: "Final Scenario 1: The Protocol Pressure",
        xp: 40,
        scenario: "Su supervisor quiere comenzar la evaluaci√≥n ma√±ana. El protocolo est√° redactado pero a√∫n no registrado en PROSPERO (tarda entre 24 y 48 h). 'Simplemente comience, podemos registrarnos m√°s tarde.'",
        question: "What do you do?",
        options: [
          { letter: "A", text: "Start screening‚Äîregistration is just paperwork", correct: false },
          { letter: "B", text: "Espere el registro antes de cualquier recopilaci√≥n de datos.", correct: true },
          { letter: "C", text: "Start screening but don't record results yet", correct: false },
          { letter: "D", text: "Submit to a faster registry service", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! El registro marca sus promesas. Comenzar antes del registro permite cambiar los resultados: el problema del 31%.",
          incorrect: "El registro debe realizarse ANTES de cualquier recopilaci√≥n de datos. Esto evita el problema de cambio de resultados del 31%."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî•", title: "Escenario final 2: La crisis",
        xp: 40,
        scenario: "Day 33. Your rerun shows RR=0.72. Collaborator's shows RR=0.68. Both significant but outside tolerance. You have 6 hours until DoD-D deadline.",
        question: "¬øCu√°l es tu primera acci√≥n?",
        options: [
          { letter: "A", text: "Promedia a 0,70 y contin√∫a", correct: false },
          { letter: "B", text: "Line-by-line input comparison", correct: true },
          { letter: "C", text: "Trigger CondGO immediately", correct: false },
          { letter: "D", text: "Ask both analysts to re-run again", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! La comparaci√≥n l√≠nea por l√≠nea encuentra la fuente de la discrepancia. En 6 horas, puede solucionarlo sin necesidad de CondGO.",
          incorrect: "First: find the source of discrepancy. Line-by-line comparison. Most mismatches have fixable causes."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚öñÔ∏è", title: "Final Scenario 3: The Ethical Edge",
        xp: 40,
        scenario: "Su metan√°lisis muestra que el medicamento X es da√±ino (RR 1,35, IC 1,10-1,65). La compa√±√≠a farmac√©utica que financi√≥ su revisi√≥n le pide que la \"replantee\" como \"no significativamente beneficiosa\".",
        question: "¬øC√≥mo responde?",
        options: [
          { letter: "A", text: "They're technically correct‚Äîreframe as requested", correct: false },
          { letter: "B", text: "Report the finding accurately: harm detected", correct: true },
          { letter: "C", text: "Compromise: say 'insufficient evidence of benefit'", correct: false },
          { letter: "D", text: "Add sensitivity analyses until harm disappears", correct: false }
        ],
        feedback: {
          correct: "Correct! RR 1.35 with CI excluding 1.0 is harm. Report it accurately. The Avandia story: suppressing harm signals kills patients.",
          incorrect: "RR 1.35 (CI 1.10-1.65) = statistically significant HARM. Report it accurately. The Avandia scandal: silence killed tens of thousands."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El costo de la espera", title: "What Silence Buys",
        text: "Between 2000 and 2004, while Merck debated what to do about Vioxx, <strong>25,000 people died</strong> from heart attacks caused by a drug they trusted. Between 1999 and 2007, while GSK buried the Avandia spreadsheet, <strong>83,000 people suffered heart attacks</strong> from a diabetes drug that was supposed to help them.",
        followup: "Estos no fueron accidentes. No eran incognoscibles. Fueron el resultado predecible de sistemas sin plazos, pruebas sin verificaci√≥n y personas que decidieron que \"esperar y ver\" era m√°s seguro que \"detenerse y comprobar\". Cada d√≠a de retraso ten√≠a un recuento de cad√°veres."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìÖ", title: "Escenario: El c√≥modo retraso",
        xp: 30,
        scenario: "Su revisi√≥n sistem√°tica encontr√≥ evidencia clara de da√±o. Su instituci√≥n quiere \"esperar los comentarios de la revisi√≥n por pares\" antes de hacer cualquier declaraci√≥n p√∫blica. El proceso de revisi√≥n por pares suele tardar entre 6 y 12 meses.",
        question: "¬øQu√© debe hacer?",
        options: [
          { letter: "A", text: "Espere la revisi√≥n por pares: el proceso adecuado es importante", correct: false },
          { letter: "B", text: "Post a preprint immediately while pursuing publication", correct: true },
          { letter: "C", text: "Share findings privately with key opinion leaders", correct: false },
          { letter: "D", text: "Accelerate peer review by submitting to multiple journals", correct: false }
        ],
        feedback: {
          correct: "Correct! Vioxx: 4 years of 'waiting' = 25,000 deaths. Avandia: 7 years = 83,000 heart attacks. When evidence shows harm, delay is not neutral‚Äîit's harmful. Preprint immediately.",
          incorrect: "Vioxx and Avandia: 'waiting' killed over 100,000 people combined. When evidence shows harm, every day of delay has a body count. Preprint findings immediately."
        }
      }},
      { type: "story", theme: "green-bg", content: {
        label: "El otro camino", title: "Frances Kelsey's 19 Months",
        text: "In 1960, the FDA received an application to approve thalidomide in America. One reviewer‚ÄîFrances Kelsey‚Äîrefused to approve it. The manufacturer pressured her. Her colleagues questioned her. She held firm for <strong>19 months</strong>, demanding evidence of safety.",
        followup: "While she waited, 10,000 children were born with deformities in countries that had approved the drug. American children were spared‚Äînot by luck, but by one person who demanded proof before action. Kelsey proved that asking for evidence isn't obstruction. It's protection. META-SPRINT exists to make that protection systematic."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üõ°Ô∏è", title: "Escenario: la presi√≥n para aprobar",
        xp: 30,
        scenario: "Est√°s revisando un nuevo tratamiento. El fabricante dice que sus \"excesivas demandas de evidencia\" est√°n retrasando el acceso a un medicamento que podr√≠a salvar vidas. Sus colegas sugieren que est√° \"siendo demasiado cauteloso\". Los abogados de la industria insin√∫an acciones legales por 'obstrucci√≥n'.",
        question: "What should guide your decision?",
        options: [
          { letter: "A", text: "Speed up approval‚Äîpatients are waiting", correct: false },
          { letter: "B", text: "Maintain evidence standards regardless of pressure", correct: true },
          { letter: "C", text: "Compromiso con aprobaci√≥n condicional", correct: false },
          { letter: "D", text: "Escalate to supervisors to share responsibility", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Frances Kelsey fue tachada de \"burocr√°tica\" durante 19 meses, mientras 10.000 ni√±os en otros pa√≠ses sufr√≠an da√±os. Salv√≥ a miles de ni√±os estadounidenses. Los est√°ndares de evidencia salvan vidas.",
          incorrect: "Kelsey fue presionada durante 19 meses para aprobar la talidomida. Su 'obstrucci√≥n' salv√≥ a miles de ni√±os. La presi√≥n y la urgencia no son pruebas. Los est√°ndares protegen a los pacientes."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "El desastre de Rezulin", title: "El medicamento para la diabetes que destruy√≥ el h√≠gado",
        text: "In 1997, Warner-Lambert launched troglitazone (Rezulin) as a revolutionary diabetes treatment. The FDA approved it despite a medical officer's objections about liver toxicity signals. <strong>Within months, reports of liver failure poured in.</strong> The UK banned it in December 1997. Japan banned it in 2000.",
        followup: "The FDA kept Rezulin on the American market until March 2000‚Äî<strong>three years after the UK acted</strong>. During those three years, at least 90 Americans died of liver failure from a drug banned elsewhere. FDA's own scientists had warned of the danger. They were overruled. When Rezulin was finally withdrawn, internal documents revealed Warner-Lambert had hidden early liver toxicity data and downplayed risks. The gap between the UK ban and US withdrawal: three years. The cost: dozens of preventable deaths. Different regulators, same data, vastly different responses."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üåç", title: "Escenario: la divergencia regulatoria",
        xp: 30,
        scenario: "Un medicamento que est√° revisando en un metan√°lisis fue retirado en Europa por motivos de seguridad Hace 2 a√±os pero sigue disponible en tu pa√≠s. Los reguladores locales citan \"evidencia insuficiente de da√±o en nuestra poblaci√≥n\". Los ensayos europeos mostraron se√±ales claras de toxicidad hep√°tica.",
        question: "¬øC√≥mo deber√≠a afectar esto a su revisi√≥n sistem√°tica?",
        options: [
          { letter: "A", text: "Utilice solo datos de su pa√≠s; las decisiones regulatorias var√≠an", correct: false },
          { letter: "B", text: "Incluya todos los datos e informe de manera destacada la divergencia regulatoria en la discusi√≥n", correct: true },
          { letter: "C", text: "Exclude the drug entirely due to safety concerns", correct: false },
          { letter: "D", text: "Trust your local regulators' interpretation", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Rezulin mat√≥ a estadounidenses durante 3 a√±os despu√©s de que el Reino Unido actuara. Su revisi√≥n debe incluir todos los datos de seguridad y resaltar las divergencias regulatorias. Los lectores necesitan informaci√≥n completa, no filtrada por fronteras geogr√°ficas.",
          incorrect: "Rezulin was banned in UK in 1997; Americans died until 2000. Regulatory decisions aren't evidence‚Äîthey're interpretations. Include all data and report divergences so readers can judge."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "El esc√°ndalo de Ketek", title: "The Antibiotic Built on Fabricated Trials",
        text: "In 2004, the FDA approved telithromycin (Ketek) for respiratory infections. The approval relied heavily on a large trial‚ÄîStudy 3014‚Äîconducted by Dr. Anne Kirkman-Campbell. She enrolled <strong>407 patients in just 9 months</strong> from a solo practice. Impossible numbers, but the FDA didn't question them.",
        followup: "Dr. Kirkman-Campbell was later convicted of fraud. She had <strong>fabricated patient enrollment entirely</strong>‚Äîsome 'patients' were relatives who never had infections. But her fake data had already supported FDA approval. When real-world use began, Ketek caused liver failures, some fatal. An FDA reviewer had flagged Study 3014's impossible enrollment before approval‚Äîshe was overruled. The drug that was approved based partly on invented patients went on to harm real ones. The question no one asked: 'How can one doctor enroll 400 patients in conditions that would take a large hospital years?'"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¢", title: "Escenario: el superinscriptor",
        xp: 30,
        scenario: "Un ensayo fundamental de medicamentos incluye datos de un m√©dico individual que inscribi√≥ a 350 pacientes en 6 meses, m√°s que los siguientes 10 sitios combinados. Los informes de monitoreo del sitio est√°n marcados como \"satisfactorios\". La prueba muestra una gran eficacia.",
        question: "What verification should occur before regulatory decisions?",
        options: [
          { letter: "A", text: "Se aprob√≥ el monitoreo del sitio, por lo que se verifican los datos", correct: false },
          { letter: "B", text: "Audit source documents: patient records, consent forms, medical histories", correct: true },
          { letter: "C", text: "Ejecute el an√°lisis con y sin los datos de este sitio", correct: false },
          { letter: "D", text: "Comun√≠quese con el investigador para obtener una explicaci√≥n sobre la alta inscripci√≥n", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Kirkman-Campbell pas√≥ el monitoreo del sitio mientras fabricaba a 407 pacientes. La verificaci√≥n del documento fuente (registros reales de pacientes) la habr√≠a atrapado. Los datos de inscripci√≥n autoinformados y el seguimiento \"satisfactorio\" no significan nada.",
          incorrect: "Dr. Kirkman-Campbell's site passed monitoring. Her patients didn't exist. Source document audits‚Äînot self-reports‚Äîcatch fabrication. Impossible enrollment rates demand verification of original records."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "The Promise", title: "Qu√© crea la evidencia confiable",
        text: "In 1987, the ISIS-2 trial showed aspirin reduces death after heart attack by 23%. The evidence was solid. The methods were transparent. The data was verifiable. Since then, aspirin after heart attack has saved an estimated <strong>100,000 lives per year</strong>.",
        followup: "That's what honest evidence creates: treatments that work, given to people who need them, saving lives that would otherwise be lost. Every protocol you register, every number you verify, every gate you pass‚Äîyou're building the foundation for the next ISIS-2. The next treatment that actually works. The next million lives saved."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üåü", title: "Escenario: su primera revisi√≥n",
        xp: 30,
        scenario: "Est√° a punto de comenzar su primera revisi√≥n sistem√°tica. Un colega de alto nivel ofrece un consejo: 'No se preocupe demasiado por todos estos protocolos y listas de verificaci√≥n. Simplemente haga un buen trabajo y la evidencia hablar√° por s√≠ misma.'",
        question: "¬øC√≥mo debe responder?",
        options: [
          { letter: "A", text: "Follow their advice‚Äîexperience beats process", correct: false },
          { letter: "B", text: "Follow META-SPRINT rigorously‚Äîsystems prevent disasters", correct: true },
          { letter: "C", text: "Adapte el proceso a su situaci√≥n espec√≠fica", correct: false },
          { letter: "D", text: "Utilice una versi√≥n m√°s ligera para su primera revisi√≥n, luego mejore", correct: false }
        ],
        feedback: {
          correct: "¬°Correcto! Las buenas intenciones no previenen los errores. La evidencia de aspirina de ISIS-2 salv√≥ 100.000 vidas al a√±o porque era rigurosa. El fraude de Polderman mat√≥ a 800.000 personas porque nadie lo verific√≥. Los sistemas, no las intenciones, protegen a los pacientes.",
          incorrect: "El 'buen trabajo' sin sistemas condujo a Poldermans, CAST, Vioxx, Avandia. ISIS-2 ahorr√≥ millones gracias a m√©todos rigurosos. La diferencia entre 100.000 salvados y 800.000 asesinados es la verificaci√≥n sistem√°tica."
        }
      }},
      { type: "stats", theme: "green-bg", content: {
        title: "Course Complete!",
        stats: [
          { value: "5", label: "Phases mastered" },
          { value: "5", label: "Gates understood" },
          { value: "8", label: "Modules completed" },
          { value: "‚àû", label: "Patients protected" }
        ],
        caption: "Ahora entiendes c√≥mo producir pruebas que salven vidas."
      }},
      { type: "refrain", theme: "black", content: { text: "Vaya a generar confianza. 40 d√≠as. 5 puertas. Evidencia que importa." }}
    ]
  }
];

// ===== NAVIGATION STATE =====
let currentModule = 0;
let currentSlide = 0;
let consecutiveCorrect = gameState.consecutiveCorrect || 0;

// ===== SAVE/LOAD =====
function saveGame() {
  safeSetStorage('metasprintGame_v1', gameState);
}

function resetProgress() {
  if (confirm('Reset all progress and achievements?')) {
    gameState = { ...DEFAULT_STATE, answeredQuestions: {}, badges: [], completedModules: [], perfectModules: [], consecutiveCorrect: 0 };
    consecutiveCorrect = 0;
    saveGame();
    currentModule = 0;
    currentSlide = 0;
    renderAll();
  }
}

// ===== GLOSSARY =====
function toggleGlossary() {
  document.getElementById('glossaryPanel').classList.toggle('open');
}

// ===== COURSE PROGRESS =====
function updateCourseProgress() {
  const totalModules = MODULES.length;
  const completedCount = gameState.completedModules.length;
  const pct = Math.round((completedCount / totalModules) * 100);
  const fillEl = document.getElementById('courseProgressFill');
  const pctEl = document.getElementById('courseProgressPct');
  if (fillEl) fillEl.style.width = pct + '%';
  if (pctEl) pctEl.textContent = pct + '%';
}

// ===== MODULE QUESTION TRACKING =====
function getModuleQuestionIds(moduleIndex) {
  const mod = MODULES[moduleIndex];
  const ids = [];
  mod.slides.forEach((slide, si) => {
    if (slide.type === 'decision') ids.push(`dec_${moduleIndex}_${si}`);
    if (slide.type === 'quiz') ids.push(`quiz_${moduleIndex}_${si}`);
    if (slide.type === 'prediction') ids.push(`pred_${moduleIndex}_${si}`);
  });
  return ids;
}

function checkPerfectModule(moduleIndex) {
  const mod = MODULES[moduleIndex];
  const questionIds = getModuleQuestionIds(moduleIndex);
  if (questionIds.length === 0) return false;

  let allCorrect = true;
  questionIds.forEach(id => {
    const answer = gameState.answeredQuestions[id];
    if (answer === undefined || answer === null) { allCorrect = false; return; }

    // Find the slide and check if answer was correct
    const parts = id.split('_');
    const slideIndex = parseInt(parts[2]);
    const slide = mod.slides[slideIndex];

    if (slide.type === 'decision') {
      const correctOpt = slide.content.options.find(o => o.correct);
      if (answer !== correctOpt?.letter) allCorrect = false;
    } else if (slide.type === 'quiz') {
      const correctIdx = slide.content.options.findIndex(o => o.correct);
      if (answer !== correctIdx) allCorrect = false;
    } else if (slide.type === 'prediction') {
      if (answer !== slide.content.answer) allCorrect = false;
    }
  });

  return allCorrect;
}

// ===== XP & LEVELING =====
function addXP(amount) {
  gameState.xp += amount;
  checkLevelUp();
  saveGame();
  updateStatsDisplay();
  showXPPopup(amount);
}

function checkLevelUp() {
  for (let i = LEVELS.length - 1; i >= 0; i--) {
    if (gameState.xp >= LEVELS[i].xp && gameState.level < LEVELS[i].level) {
      gameState.level = LEVELS[i].level;
      showLevelUp(LEVELS[i]);
      break;
    }
  }
}

function showXPPopup(amount) {
  const popup = document.getElementById('xpPopup');
  document.getElementById('xpAmount').textContent = `+${amount}`;
  popup.classList.add('show');
  setTimeout(() => popup.classList.remove('show'), 1500);
}

function showLevelUp(levelData) {
  triggerConfetti();
  showBadgeModal({ icon: levelData.icon, name: `Level ${levelData.level}`, desc: levelData.title });
}

// ===== BADGES =====
function awardBadge(badgeId) {
  if (gameState.badges.includes(badgeId)) return;
  gameState.badges.push(badgeId);
  saveGame();
  const badge = BADGES.find(b => b.id === badgeId);
  if (badge) showBadgeModal(badge);
  updateBadges();
}

function awardBadgeIfNew(id, icon, name, desc) {
  if (gameState.badges.includes(id)) return;
  gameState.badges.push(id);
  saveGame();
  showBadgeModal({ icon, name, desc });
  updateBadges();
}

function showBadgeModal(badge) {
  const modal = document.getElementById('badgeModal');
  // Remove any existing focus trap handler before adding a new one
  if (modal._focusTrapHandler) {
    modal.removeEventListener('keydown', modal._focusTrapHandler);
  }
  document.getElementById('badgeModalIcon').textContent = badge.icon;
  document.getElementById('badgeModalTitle').textContent = badge.name;
  document.getElementById('badgeModalDesc').textContent = badge.desc;
  modal.classList.add('show');
  triggerConfetti();

  // Focus trap for accessibility
  const focusableElements = modal.querySelectorAll('button, [tabindex]:not([tabindex="-1"])');
  if (focusableElements.length > 0) {
    focusableElements[0].focus();
  }
  const trapHandler = function(e) {
    if (e.key === 'Escape') {
      closeBadgeModal();
      return;
    }
    if (e.key === 'Tab') {
      const firstFocusable = focusableElements[0];
      const lastFocusable = focusableElements[focusableElements.length - 1];
      if (e.shiftKey && document.activeElement === firstFocusable) {
        e.preventDefault();
        lastFocusable.focus();
      } else if (!e.shiftKey && document.activeElement === lastFocusable) {
        e.preventDefault();
        firstFocusable.focus();
      }
    }
  };
  modal._focusTrapHandler = trapHandler;
  modal.addEventListener('keydown', trapHandler);
}

function closeBadgeModal() {
  const modal = document.getElementById('badgeModal');
  if (modal._focusTrapHandler) {
    modal.removeEventListener('keydown', modal._focusTrapHandler);
    delete modal._focusTrapHandler;
  }
  modal.classList.remove('show');
}

// ===== STREAK =====
function updateStreak() {
  const today = new Date().toDateString();
  if (gameState.lastActive !== today) {
    const yesterday = new Date(Date.now() - 86400000).toDateString();
    if (gameState.lastActive === yesterday) {
      gameState.streak++;
      if (gameState.streak >= 3) awardBadge('streak_3');
      if (gameState.streak >= 7) awardBadge('streak_7');
    } else if (gameState.lastActive) {
      gameState.streak = 1;
    } else {
      gameState.streak = 1;
    }
    gameState.lastActive = today;
    saveGame();
  }
}

// ===== CONFETTI =====
function triggerConfetti() {
  // Respect reduced motion preference
  if (window.matchMedia('(prefers-reduced-motion: reduce)').matches) return;

  const container = document.getElementById('confettiContainer');
  const colors = ['#D4AF37', '#22c55e', '#3b82f6', '#f59e0b', '#ef4444', '#7c3aed'];
  for (let i = 0; i < 50; i++) {
    const confetti = document.createElement('div');
    confetti.className = 'confetti';
    confetti.style.left = Math.random() * 100 + '%';
    confetti.style.background = colors[Math.floor(Math.random() * colors.length)];
    confetti.style.animationDelay = Math.random() * 0.5 + 's';
    confetti.style.transform = `rotate(${Math.random() * 360}deg)`;
    container.appendChild(confetti);
    setTimeout(() => confetti.remove(), 3500);
  }
}

// ===== COMBO COUNTER =====
function updateComboDisplay() {
  const comboEl = document.getElementById('comboDisplay');
  const countEl = document.getElementById('comboCount');

  if (consecutiveCorrect >= 2) {
    countEl.textContent = consecutiveCorrect;
    comboEl.classList.add('show');

    // Animate for big combos
    if (consecutiveCorrect >= 5) {
      comboEl.classList.add('big');
      setTimeout(() => comboEl.classList.remove('big'), 300);
    }
  } else {
    comboEl.classList.remove('show');
  }
}

// ===== MOBILE SIDEBAR =====
function toggleSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.getElementById('sidebarOverlay');
  sidebar.classList.toggle('open');
  overlay.classList.toggle('show');
  var btn = document.querySelector('.sidebar-toggle, .hamburger, .mobile-menu-btn'); if (btn) btn.setAttribute('aria-expanded', btn.getAttribute('aria-expanded') === 'true' ? 'false' : 'true');
}

// ===== RENDER =====
function renderAll() {
  updateStreak();
  renderSidebar();
  renderSlides();
  updateStatsDisplay();
  updateBadges();
  updateCourseProgress();
}

function updateStatsDisplay() {
  const levelData = LEVELS.find(l => l.level === gameState.level) || LEVELS[0];
  const nextLevel = LEVELS.find(l => l.level === gameState.level + 1);

  document.getElementById('levelIcon').textContent = levelData.icon;
  document.getElementById('levelTitle').textContent = levelData.title;
  document.getElementById('levelNum').textContent = gameState.level;

  const currentXP = gameState.xp - levelData.xp;
  const neededXP = nextLevel ? (nextLevel.xp - levelData.xp) : 500;
  const pct = Math.min(100, (currentXP / neededXP) * 100);

  document.getElementById('xpFill').style.width = pct + '%';
  document.getElementById('xpCurrent').textContent = currentXP;
  document.getElementById('xpNeeded').textContent = neededXP;

  document.getElementById('correctCount').textContent = gameState.correctAnswers;
  document.getElementById('decisionCount').textContent = gameState.decisionsCompleted;
  document.getElementById('predictCount').textContent = gameState.predictionsCorrect;
  document.getElementById('streakCount').textContent = gameState.streak;

  const streakEl = document.getElementById('streakDisplay');
  streakEl.classList.toggle('active', gameState.streak > 0);
}

function updateBadges() {
  const grid = document.getElementById('badgesGrid');
  grid.innerHTML = BADGES.map(b => {
    const earned = gameState.badges.includes(b.id);
    let progress = '';

    // Show progress for certain badges
    if (!earned) {
      if (b.id === 'oracle') progress = `${gameState.predictionsCorrect}/5`;
      if (b.id === 'decision_maker') progress = `${gameState.decisionsCompleted}/10`;
      if (b.id === 'streak_3') progress = `${Math.min(gameState.streak, 3)}/3`;
      if (b.id === 'streak_7') progress = `${Math.min(gameState.streak, 7)}/7`;
      if (b.id === 'finisher') progress = `${gameState.completedModules.length}/${MODULES.length}`;
    }

    return `
      <button class="badge-item ${earned ? 'earned' : ''}" data-tooltip="${b.name}: ${b.desc}" aria-label="${b.name}: ${b.desc}${earned ? ' (Earned)' : ''}">
        ${b.icon}
        ${progress && !earned ? `<span class="badge-progress">${progress}</span>` : ''}
      </button>
    `;
  }).join('');
}

function renderSidebar() {
  const list = document.getElementById('moduleList');
  list.innerHTML = MODULES.map((mod, i) => {
    const completed = gameState.completedModules.includes(mod.id);
    const locked = i > 0 && !gameState.completedModules.includes(MODULES[i-1].id);
    // Estimate ~1.5 min per slide
    const estMins = Math.round(mod.slides.length * 1.5);
    return `
      <div class="module-item ${i === currentModule ? 'active' : ''} ${completed ? 'completed' : ''} ${locked ? 'locked' : ''}"
           onclick="${locked ? '' : `goToModule(${i})`}"
           role="button"
           tabindex="${locked ? -1 : 0}"
           aria-label="${mod.title}${completed ? ' (completed)' : ''}${locked ? ' (locked)' : ''}">
        <div class="module-number">${completed ? '‚úì' : (locked ? 'üîí' : mod.id)}</div>
        <div class="module-info">
          <div class="module-title">${mod.title}</div>
          <div class="module-subtitle">${mod.subtitle}</div>
          <div class="module-xp">+${mod.xp} XP</div>
          <div class="module-time">‚è±Ô∏è ~${estMins} min</div>
        </div>
      </div>
    `;
  }).join('');
}

function renderSlides() {
  const container = document.getElementById('main-content');
  container.innerHTML = MODULES.map((mod, mi) => {
    const progressPct = ((currentSlide + 1) / mod.slides.length) * 100;
    return `
    <div class="module-slides ${mi === currentModule ? 'active' : ''}" data-module="${mi}">
      <div class="slide-progress-bar" style="width: ${mi === currentModule ? progressPct : 0}%"></div>
      ${mod.slides.map((slide, si) => renderSlide(slide, si, mi)).join('')}
      <div class="slide-nav">
        <button class="nav-btn" onclick="prevSlide()" aria-label="Previous slide" ${currentSlide === 0 ? 'disabled' : ''}>‚Üê</button>
        <div class="nav-center">
          <div class="slide-counter">${currentSlide + 1} / ${mod.slides.length}</div>
          <div class="progress-dots">
            ${mod.slides.map((_, i) => `<button class="progress-dot ${i === currentSlide ? 'active' : ''}" type="button" onclick="goToSlide(${i})" aria-label="Go to slide ${i + 1}" ${i === currentSlide ? 'aria-current="true"' : ''}></button>`).join('')}
          </div>
        </div>
        <button class="nav-btn" onclick="nextSlide()" aria-label="Next slide">‚Üí</button>
      </div>
    </div>
  `;
  }).join('');
  document.getElementById('currentModule').textContent = MODULES[currentModule].title;
  updateSlideVisibility();
}

function renderSlide(slide, index, moduleIndex) {
  const theme = slide.theme || 'dark';
  let html = `<div class="slide ${theme} ${index === currentSlide ? 'active' : ''}" data-slide="${index}">`;

  switch(slide.type) {
    case 'title':
      html += `<div class="content"><h1 class="title gold animate">${slide.content.title}</h1><p class="subtitle animate delay-1">${slide.content.subtitle}</p></div>`;
      break;

    case 'objectives':
      html += `<div class="content">
        <div class="objectives-box animate">
          <div class="objectives-header">
            <div class="objectives-icon">üéØ</div>
            <div class="objectives-title">Learning Objectives</div>
          </div>
          <ul class="objectives-list">
            ${slide.content.objectives.map(obj => `<li>${obj}</li>`).join('')}
          </ul>
        </div>
        ${slide.content.tip ? `<p class="subtitle animate delay-1" style="font-size:0.85rem;max-width:600px">${slide.content.tip}</p>` : ''}
      </div>`;
      break;

    case 'summary':
      const modXP = MODULES[moduleIndex]?.xp || 0;
      const isPerfect = checkPerfectModule(moduleIndex);
      html += `<div class="content">
        <div class="summary-box animate">
          <div class="summary-icon">üéâ</div>
          <div class="summary-title">Module Complete!</div>
          <div class="summary-stats">
            <div class="summary-stat">
              <div class="summary-stat-value">+${modXP}</div>
              <div class="summary-stat-label">XP Earned</div>
            </div>
            <div class="summary-stat">
              <div class="summary-stat-value">${gameState.correctAnswers}</div>
              <div class="summary-stat-label">Total Correct</div>
            </div>
          </div>
          ${isPerfect ? `<div class="perfect-bonus animate delay-1">‚≠ê PERFECT MODULE +${Math.round(modXP * 0.5)} XP ‚≠ê</div>` : ''}
          <p class="subtitle" style="margin-top:1rem;font-size:0.85rem">${slide.content.summary || '¬°Excelente trabajo! Contin√∫e con el siguiente m√≥dulo.'}</p>
          <button class="summary-next animate delay-2" onclick="nextSlide()">Continue to Next Module ‚Üí</button>
        </div>
      </div>`;
      break;

    case 'story':
      html += `<div class="content">
        <article class="story-box ${slide.content.success ? 'success' : ''} animate" role="article" aria-label="Case study: ${slide.content.label}">
          <div class="story-label">${slide.content.label}</div>
          ${slide.content.title ? `<h2 class="title gold" style="font-size:1.8rem;margin-bottom:0.75rem">${slide.content.title}</h2>` : ''}
          <p class="story-text">${slide.content.text}</p>
          ${slide.content.followup ? `<p class="story-text" style="margin-top:0.75rem;font-style:italic;opacity:0.9">${slide.content.followup}</p>` : ''}
        </article>
      </div>`;
      break;

    case 'stats':
      html += `<div class="content">
        ${slide.content.title ? `<h2 class="title gold animate">${slide.content.title}</h2>` : ''}
        ${slide.content.subtitle ? `<p class="subtitle animate delay-1">${slide.content.subtitle}</p>` : ''}
        <div class="stats-grid animate delay-2">
          ${slide.content.stats.map(s => `<div class="stat-box"><div class="stat-value gold">${s.value}</div><div class="stat-label">${s.label}</div></div>`).join('')}
        </div>
        ${slide.content.caption ? `<p class="subtitle animate delay-3" style="font-size:0.85rem;margin-top:0.75rem">${slide.content.caption}</p>` : ''}
      </div>`;
      break;

    case 'refrain':
      html += `<div class="content" style="justify-content:center;height:100%"><p class="refrain animate">"${slide.content.text}"</p></div>`;
      break;

    case 'lesson':
      html += `<div class="content">
        <h2 class="title ${theme === 'light' ? 'navy' : 'gold'} animate">${slide.content.title}</h2>
        <div class="animate delay-1">
          ${slide.content.lessons.map((l, i) => `
            <div class="lesson-item">
              <div class="lesson-number">${i + 1}</div>
              <div class="lesson-content"><h4>${l.title}</h4><p>${l.desc}</p></div>
            </div>
          `).join('')}
        </div>
      </div>`;
      break;

    case 'timeline':
      html += `<div class="content">
        <h2 class="title gold animate">${slide.content.title}</h2>
        <div class="timeline animate delay-1">
          ${slide.content.items.map(item => `
            <div class="timeline-item phase-${item.phase || ''}">
              <div class="timeline-days">${item.days}</div>
              <div class="timeline-content">
                <div class="timeline-title">${item.title}</div>
                <div class="timeline-desc">${item.desc}</div>
              </div>
            </div>
          `).join('')}
        </div>
      </div>`;
      break;

    case 'checklist':
      html += `<div class="content">
        <h2 class="title gold animate">${slide.content.title}</h2>
        <div class="checklist animate delay-1">
          ${slide.content.items.map(item => `
            <div class="checklist-item">
              <div class="check-icon">‚úì</div>
              <div class="checklist-text">${item}</div>
            </div>
          `).join('')}
        </div>
      </div>`;
      break;

    case 'concept':
      html += `<div class="content">
        <h2 class="title ${theme === 'light' ? 'navy' : 'gold'} animate">${slide.content.title}</h2>
        ${slide.content.subtitle ? `<p class="subtitle animate delay-1">${slide.content.subtitle}</p>` : ''}
        ${slide.content.text ? `<div class="card ${theme === 'light' ? '' : 'navy-bg'} animate delay-2"><p class="card-text">${slide.content.text}</p></div>` : ''}
        ${slide.content.highlight ? `<div class="story-box warning animate delay-3"><div class="story-label">Key Insight</div><p class="story-text">${slide.content.highlight}</p></div>` : ''}
        ${slide.content.checkpoints ? `
          <div class="timeline animate delay-2" style="margin-top:0.75rem">
            ${slide.content.checkpoints.map(cp => `
              <div class="timeline-item"><div class="timeline-days">${cp.day}</div><div class="timeline-content"><div class="timeline-title">${cp.event}</div></div></div>
            `).join('')}
          </div>
        ` : ''}
        ${slide.content.allowed ? `
          <div class="card green-border animate delay-2" style="margin-top:0.75rem">
            <div class="card-label" style="color:var(--green)">‚úì Allowed</div>
            <ul style="margin-left:1.25rem;font-size:0.9rem">${slide.content.allowed.map(a => `<li>${a}</li>`).join('')}</ul>
          </div>
          <div class="card red-border animate delay-3">
            <div class="card-label" style="color:var(--red)">‚úó Forbidden</div>
            <ul style="margin-left:1.25rem;font-size:0.9rem">${slide.content.forbidden.map(f => `<li>${f}</li>`).join('')}</ul>
          </div>
        ` : ''}
      </div>`;
      break;

    case 'takeaway':
      html += `<div class="content">
        <div class="takeaway-card animate">
          <div class="takeaway-label"><span class="takeaway-icon">üí°</span>Key Takeaway</div>
          <p class="takeaway-text">${slide.content.text}</p>
        </div>
      </div>`;
      break;

    case 'prediction':
      const pid = `pred_${moduleIndex}_${index}`;
      const answered = gameState.answeredQuestions[pid];
      html += `<div class="content">
        <div class="prediction-panel animate" id="${pid}_panel">
          <div class="prediction-icon">${slide.content.icon}</div>
          <div class="prediction-title">${slide.content.title}</div>
          <p class="prediction-subtitle">${slide.content.subtitle}</p>
          <div class="prediction-buttons" id="${pid}_buttons">
            ${slide.content.options.map(opt => `
              <button class="predict-btn ${opt.id === 'benefit' ? 'benefit' : opt.id === 'harm' ? 'harm' : 'neutral'} ${answered === opt.id ? 'selected' : ''}"
                      onclick="makePrediction('${pid}', '${opt.id}', '${slide.content.answer}', ${slide.content.xp})"
                      ${answered ? 'disabled' : ''}>
                ${opt.label}<br><small>${opt.text}</small>
              </button>
            `).join('')}
          </div>
          <div class="prediction-result ${answered ? 'show' : ''} ${answered === slide.content.answer ? 'correct' : 'incorrect'}" id="${pid}_result">
            ${answered === slide.content.answer ? '‚úì ¬°Tu intuici√≥n era correcta!' : answered ? '‚úó Los datos te sorprendieron, ¬°es bueno saberlo!' : ''}
          </div>
        </div>
      </div>`;
      break;

    case 'decision':
      const did = `dec_${moduleIndex}_${index}`;
      const decAnswered = gameState.answeredQuestions[did];
      html += `<div class="content">
        <div class="decision-tree animate">
          <div class="decision-header">
            <div class="decision-icon">${slide.content.icon}</div>
            <div><div class="decision-title">${slide.content.title}</div></div>
            <div class="decision-xp">+${slide.content.xp} XP</div>
          </div>
          <div class="decision-scenario">${slide.content.scenario}</div>
          <div class="decision-question">${slide.content.question}</div>
          <div class="decision-options" id="${did}_options">
            ${slide.content.options.map((opt, oi) => `
              <div class="decision-option ${decAnswered === opt.letter ? (opt.correct ? 'correct' : 'incorrect') : ''} ${decAnswered && opt.correct ? 'correct' : ''} ${decAnswered ? 'disabled' : ''}"
                   onclick="makeDecision('${did}', '${opt.letter}', ${opt.correct}, ${slide.content.xp})"
                   tabindex="${decAnswered ? -1 : 0}"
                   role="button"
                   aria-label="Option ${opt.letter}: ${opt.text}"
                   onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();makeDecision('${did}', '${opt.letter}', ${opt.correct}, ${slide.content.xp});}">
                <div class="option-letter">${opt.letter}</div>
                <div class="option-text">${opt.text}</div>
              </div>
            `).join('')}
          </div>
          <div class="decision-feedback ${decAnswered ? 'show' : ''} ${decAnswered && slide.content.options.find(o => o.letter === decAnswered)?.correct ? 'correct' : 'incorrect'}" id="${did}_feedback">
            <div class="feedback-title">${decAnswered && slide.content.options.find(o => o.letter === decAnswered)?.correct ? '‚úì Correct!' : '‚úó Not quite'}</div>
            <div class="feedback-text">${decAnswered && slide.content.options.find(o => o.letter === decAnswered)?.correct ? slide.content.feedback.correct : slide.content.feedback.incorrect}</div>
          </div>
        </div>
      </div>`;
      break;

    case 'quiz':
      const qid = `quiz_${moduleIndex}_${index}`;
      const qAnswered = gameState.answeredQuestions[qid];
      html += `<div class="content">
        <div class="quiz-container animate">
          <p class="quiz-question">${slide.content.question}</p>
          <div class="quiz-options" id="${qid}_options">
            ${slide.content.options.map((opt, i) => `
              <div class="quiz-option ${qAnswered === i ? (opt.correct ? 'correct' : 'incorrect') : ''} ${qAnswered !== undefined && opt.correct ? 'correct' : ''} ${qAnswered !== undefined ? 'disabled' : ''}"
                   onclick="answerQuiz('${qid}', ${i}, ${opt.correct}, ${slide.content.xp || 20})">
                ${opt.text}
              </div>
            `).join('')}
          </div>
          <div class="quiz-feedback ${qAnswered !== undefined ? 'show' : ''} ${qAnswered !== undefined && slide.content.options[qAnswered]?.correct ? 'correct' : 'incorrect'}" id="${qid}_feedback">
            ${qAnswered !== undefined ? (slide.content.options[qAnswered]?.correct ? slide.content.feedback.correct : slide.content.feedback.incorrect) : ''}
          </div>
        </div>
      </div>`;
      break;
  }

  html += '</div>';
  return html;
}

function updateSlideVisibility() {
  const moduleSlides = document.querySelector(`.module-slides[data-module="${currentModule}"]`);
  if (!moduleSlides) return;
  moduleSlides.querySelectorAll('.slide').forEach((slide, i) => slide.classList.toggle('active', i === currentSlide));
  const counter = moduleSlides.querySelector('.slide-counter');
  if (counter) counter.textContent = `${currentSlide + 1} / ${MODULES[currentModule].slides.length}`;
  moduleSlides.querySelectorAll('.progress-dot').forEach((dot, i) => dot.classList.toggle('active', i === currentSlide));
  const prevBtn = moduleSlides.querySelector('.nav-btn:first-child');
  if (prevBtn) prevBtn.disabled = currentSlide === 0;
}

// ===== INTERACTIONS =====
function makePrediction(pid, choice, answer, xp) {
  if (gameState.answeredQuestions[pid]) return;
  gameState.answeredQuestions[pid] = choice;
  gameState.predictionsTotal++;

  const correct = choice === answer;
  if (correct) {
    gameState.predictionsCorrect++;
    addXP(xp);
    if (gameState.predictionsCorrect >= 5) awardBadge('oracle');
  }
  saveGame();
  renderSlides();
}

function makeDecision(did, choice, correct, xp) {
  if (gameState.answeredQuestions[did]) return;
  gameState.answeredQuestions[did] = choice;
  gameState.decisionsCompleted++;

  if (correct) {
    gameState.correctAnswers++;
    consecutiveCorrect++;
    addXP(xp);
    if (gameState.correctAnswers === 1) awardBadge('first_blood');
    if (consecutiveCorrect >= 5) awardBadge('perfect_5');
    if (gameState.decisionsCompleted >= 10) awardBadge('decision_maker');
  } else {
    consecutiveCorrect = 0;
  }
  gameState.consecutiveCorrect = consecutiveCorrect;
  saveGame();
  renderSlides();
  updateReviewButton();
  updateComboDisplay();
}

function answerQuiz(qid, choice, correct, xp) {
  if (gameState.answeredQuestions[qid] !== undefined) return;
  gameState.answeredQuestions[qid] = choice;

  if (correct) {
    gameState.correctAnswers++;
    consecutiveCorrect++;
    addXP(xp);
    if (gameState.correctAnswers === 1) awardBadge('first_blood');
    if (consecutiveCorrect >= 5) awardBadge('perfect_5');
  } else {
    consecutiveCorrect = 0;
  }
  gameState.consecutiveCorrect = consecutiveCorrect;
  saveGame();
  renderSlides();
  updateReviewButton();
  updateComboDisplay();
}

// ===== NAVIGATION =====
function goToModule(index) {
  if (index > 0 && !gameState.completedModules.includes(MODULES[index-1].id)) return;
  currentModule = index;
  currentSlide = 0;
  renderSlides();
  renderSidebar();
}

function goToSlide(index) {
  currentSlide = index;
  updateSlideVisibility();
}

function nextSlide() {
  const mod = MODULES[currentModule];
  if (currentSlide < mod.slides.length - 1) {
    currentSlide++;
    updateSlideVisibility();
  } else {
    completeModule();
  }
}

function prevSlide() {
  if (currentSlide > 0) {
    currentSlide--;
    updateSlideVisibility();
  }
}

function completeModule() {
  const mod = MODULES[currentModule];
  if (!gameState.completedModules.includes(mod.id)) {
    gameState.completedModules.push(mod.id);
    addXP(mod.xp);

    // Check for perfect module (all questions correct)
    if (checkPerfectModule(currentModule) && !gameState.perfectModules.includes(mod.id)) {
      gameState.perfectModules.push(mod.id);
      const bonusXP = Math.round(mod.xp * 0.5);
      addXP(bonusXP);
      showPerfectBonus(bonusXP);
    }

    // Check for module-specific badges
    if (mod.id === 3) awardBadge('protocol_pro');
    if (mod.id === 4) awardBadge('search_savant');
    if (mod.id === 5) awardBadge('data_detective');
    if (mod.id === 6) awardBadge('stats_wizard');
    if (mod.id === 8) awardBadge('colchicine_hero');
    if (gameState.completedModules.length === MODULES.length) {
      awardBadge('finisher');
      setTimeout(showCompletionModal, 500);
    }

    saveGame();
    triggerConfetti();
    updateCourseProgress();
  }

  if (currentModule < MODULES.length - 1) {
    goToModule(currentModule + 1);
  }
}

function showPerfectBonus(xp) {
  const popup = document.getElementById('xpPopup');
  document.getElementById('xpAmount').innerHTML = `+${xp}<br><small style="font-size:0.8rem">PERFECT!</small>`;
  popup.classList.add('show');
  setTimeout(() => {
    popup.classList.remove('show');
    document.getElementById('xpAmount').textContent = '+0';
  }, 2000);
}

// ===== CERTIFICATE DOWNLOAD =====
function downloadCertificate() {
  const courseName = 'META-SPRINT: 40 d√≠as para obtener evidencia confiable';
  const completionDate = new Date().toLocaleDateString('en-US', { year: 'numeric', month: 'long', day: 'numeric' });
  const level = LEVELS[gameState.level - 1] || LEVELS[0];
  const badgeCount = gameState.badges.length;
  const totalXP = gameState.xp;

  const certHTML = `
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Certificate of Completion - ${courseName}</title>
  <style>
    @import url('https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&family=Source+Sans+Pro:wght@400;600&display=swap');
    * { margin: 0; padding: 0; box-sizing: border-box; }
    body { font-family: 'Source Sans Pro', sans-serif; background: #f5f5f5; padding: 20px; }
    .certificate {
      max-width: 800px; margin: 0 auto; background: linear-gradient(135deg, #1E2761 0%, #141B3D 100%);
      border: 8px solid #D4AF37; border-radius: 12px; padding: 60px 50px; text-align: center;
      box-shadow: 0 20px 60px rgba(0,0,0,0.3);
    }
    .cert-header { font-family: 'Cormorant Garamond', serif; color: #D4AF37; font-size: 1rem; letter-spacing: 0.3em; text-transform: uppercase; margin-bottom: 10px; }
    .cert-title { font-family: 'Cormorant Garamond', serif; color: #FAF8F5; font-size: 3rem; font-weight: 700; margin-bottom: 30px; }
    .cert-subtitle { color: rgba(255,255,255,0.8); font-size: 1.1rem; margin-bottom: 40px; }
    .cert-course { font-family: 'Cormorant Garamond', serif; color: #D4AF37; font-size: 2rem; font-weight: 600; margin-bottom: 15px; padding: 20px; border-top: 1px solid rgba(212,175,55,0.3); border-bottom: 1px solid rgba(212,175,55,0.3); }
    .cert-stats { display: flex; justify-content: center; gap: 40px; margin: 30px 0; }
    .cert-stat { text-align: center; }
    .cert-stat-value { font-family: 'Cormorant Garamond', serif; font-size: 2rem; color: #D4AF37; font-weight: 700; }
    .cert-stat-label { font-size: 0.8rem; color: rgba(255,255,255,0.6); text-transform: uppercase; letter-spacing: 0.1em; }
    .cert-date { color: rgba(255,255,255,0.7); font-size: 0.95rem; margin-top: 40px; }
    .cert-footer { margin-top: 40px; padding-top: 30px; border-top: 1px solid rgba(212,175,55,0.2); }
    .cert-issuer { color: rgba(255,255,255,0.5); font-size: 0.85rem; }
    .cert-badge { display: inline-block; margin-top: 15px; padding: 8px 20px; background: rgba(212,175,55,0.2); border: 1px solid rgba(212,175,55,0.4); border-radius: 20px; color: #D4AF37; font-size: 0.9rem; }
    @media print {
      body { background: white; padding: 0; }
      .certificate { box-shadow: none; }
    }
  </style>
</head>
<body>
  <div class="certificate">
    <div class="cert-header">Synthesis Course Collection</div>
    <div class="cert-title">Certificate of Completion</div>
    <div class="cert-subtitle">This certifies successful completion of</div>
    <div class="cert-course">${courseName}</div>
    <div class="cert-stats">
      <div class="cert-stat">
        <div class="cert-stat-value">${totalXP.toLocaleString()}</div>
        <div class="cert-stat-label">Total XP Earned</div>
      </div>
      <div class="cert-stat">
        <div class="cert-stat-value">${badgeCount}</div>
        <div class="cert-stat-label">Badges Earned</div>
      </div>
      <div class="cert-stat">
        <div class="cert-stat-value">${level.title}</div>
        <div class="cert-stat-label">Final Level</div>
      </div>
    </div>
    <div class="cert-date">Completed on ${completionDate}</div>
    <div class="cert-footer">
      <div class="cert-issuer">Synthesis Course Collection ‚Äî Evidence Synthesis & Meta-Analysis Training</div>
      <div class="cert-badge">Verified Completion</div>
    </div>
  </div>
  <script>window.onload = () => window.print();<\/script>
</body>
</html>`;

  const blob = new Blob([certHTML], { type: 'text/html' });
  const url = URL.createObjectURL(blob);
  const a = document.createElement('a');
  a.href = url;
  a.download = 'Certificate-META-SPRINT-Course.html';
  document.body.appendChild(a);
  a.click();
  document.body.removeChild(a);
  URL.revokeObjectURL(url);
}

// ===== KEYBOARD =====
document.addEventListener('keydown', (e) => {
  // Close modals with Escape
  if (e.key === 'Escape') {
    closeBadgeModal();
    document.getElementById('glossaryPanel').classList.remove('open');
    document.getElementById('completionModal').classList.remove('show');
    document.getElementById('reviewPanel').classList.remove('show');
    // Close mobile sidebar
    document.querySelector('.sidebar').classList.remove('open');
    document.getElementById('sidebarOverlay').classList.remove('show');
    return;
  }
  // Keyboard support for interactive elements (check first to avoid intercepting their keys)
  if ((e.target.classList.contains('module-item') || e.target.classList.contains('decision-option') || e.target.classList.contains('quiz-option')) && (e.key === 'Enter' || e.key === ' ')) {
    e.preventDefault();
    e.target.click();
    return;
  }
  // Don't navigate if review panel is open
  if (document.getElementById('reviewPanel').classList.contains('show')) return;
  // Navigation
  if (e.key === 'ArrowRight' || e.key === ' ') { e.preventDefault(); nextSlide(); }
  else if (e.key === 'ArrowLeft') { e.preventDefault(); prevSlide(); }
});

// ===== TOUCH/SWIPE =====
let touchStartX = 0;
let touchEndX = 0;

document.addEventListener('touchstart', (e) => {
  touchStartX = e.changedTouches[0].screenX;
}, { passive: true });

document.addEventListener('touchend', (e) => {
  touchEndX = e.changedTouches[0].screenX;
  handleSwipe();
}, { passive: true });

function handleSwipe() {
  const swipeThreshold = 50;
  const diff = touchStartX - touchEndX;
  if (Math.abs(diff) < swipeThreshold) return;

  if (diff > 0) {
    // Swipe left = next; guard against swiping past last slide of completed module
    const mod = MODULES[currentModule];
    if (currentSlide >= mod.slides.length - 1 && gameState.completedModules.includes(mod.id)) return;
    nextSlide();
  } else {
    // Swipe right = prev
    prevSlide();
  }
}

// ===== STREAK WARNING =====
function checkStreakWarning() {
  const today = new Date().toDateString();
  const streakEl = document.getElementById('streakDisplay');
  if (gameState.lastActive && gameState.lastActive !== today && gameState.streak > 0) {
    // User has a streak but hasn't engaged today
    const lastDate = new Date(gameState.lastActive);
    const now = new Date();
    const hoursSince = (now - lastDate) / (1000 * 60 * 60);
    if (hoursSince > 20 && hoursSince < 48) {
      // Streak at risk!
      streakEl.classList.add('streak-warning');
      streakEl.title = '¬°Completa una lecci√≥n hoy para mantener tu racha!';
    }
  }
}

// ===== COMPLETION MODAL =====
function showCompletionModal() {
  document.getElementById('finalXP').textContent = gameState.xp;
  document.getElementById('finalCorrect').textContent = gameState.correctAnswers;
  document.getElementById('finalBadges').textContent = gameState.badges.length;
  document.getElementById('completionModal').classList.add('show');
  triggerConfetti();
  setTimeout(triggerConfetti, 500);
  setTimeout(triggerConfetti, 1000);
}

function closeCompletionModal() {
  document.getElementById('completionModal').classList.remove('show');
}

// ===== REVIEW MISTAKES =====
function updateReviewButton() {
  const mistakes = getIncorrectAnswers();
  const btn = document.getElementById('reviewMistakesBtn');
  if (mistakes.length > 0) {
    btn.classList.add('show');
    btn.textContent = `üìù Review ${mistakes.length} Mistake${mistakes.length > 1 ? 's' : ''}`;
  } else {
    btn.classList.remove('show');
  }
}

function getIncorrectAnswers() {
  const mistakes = [];
  MODULES.forEach((mod, mi) => {
    mod.slides.forEach((slide, si) => {
      if (slide.type === 'decision') {
        const did = `dec_${mi}_${si}`;
        const answer = gameState.answeredQuestions[did];
        if (answer) {
          const correct = slide.content.options.find(o => o.correct);
          const chosen = slide.content.options.find(o => o.letter === answer);
          if (chosen && !chosen.correct) {
            mistakes.push({
              module: mod.title,
              question: slide.content.question,
              scenario: slide.content.scenario,
              yourAnswer: chosen.text,
              correctAnswer: correct.text,
              explanation: slide.content.feedback.correct
            });
          }
        }
      }
      if (slide.type === 'quiz') {
        const qid = `quiz_${mi}_${si}`;
        const answer = gameState.answeredQuestions[qid];
        if (answer !== undefined) {
          const chosen = slide.content.options[answer];
          if (chosen && !chosen.correct) {
            const correct = slide.content.options.find(o => o.correct);
            mistakes.push({
              module: mod.title,
              question: slide.content.question,
              scenario: null,
              yourAnswer: chosen.text,
              correctAnswer: correct.text,
              explanation: slide.content.feedback.correct
            });
          }
        }
      }
    });
  });
  return mistakes;
}

function showReviewPanel() {
  const mistakes = getIncorrectAnswers();
  const content = document.getElementById('reviewContent');

  if (mistakes.length === 0) {
    content.innerHTML = '<p style="text-align:center;opacity:0.7;padding:2rem">No mistakes to review. Great job!</p>';
  } else {
    content.innerHTML = mistakes.map(m => `
      <div class="review-item">
        <div class="review-module">${m.module}</div>
        ${m.scenario ? `<div class="review-question" style="font-size:0.85rem;opacity:0.8;margin-bottom:0.5rem">${m.scenario}</div>` : ''}
        <div class="review-question">${m.question}</div>
        <div class="review-your-answer">‚ùå Your answer: ${m.yourAnswer}</div>
        <div class="review-correct-answer">‚úì Correct: ${m.correctAnswer}</div>
        <div class="review-explanation">${m.explanation}</div>
      </div>
    `).join('');
  }

  document.getElementById('reviewPanel').classList.add('show');
}

function closeReviewPanel() {
  document.getElementById('reviewPanel').classList.remove('show');
}

// ===== INIT =====
renderAll();
checkStreakWarning();
updateReviewButton();
</script>
</body>
</html>
